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ABSTRACT 
The viral proteins of porcine reproductive and respiratory syndrome virus 
(PRRSV) were expressed in a baculovirus expression system. They were 
evaluated for protection of pigs against the respiratory disease and for function in 
virus-cell interactions. The open reading frames 2 to 6 products were confirmed to 
be membrane associated proteins as they were detected on the surface of viable 
insect cells by an immunofluorescence assay. Immunization of pigs with vaccines 
comprised of a combination of GP2, GPS and GP4 or a combination of GPS, M and 
N proteins induced partial protection, but immunization with combination of GPS 
and M proteins failed to induce protection. Immunization of pigs with the first two 
vaccines significantly reduced the severity of clinical respiratory disease (P < 
0.001), severity of pneumonia (P < O.OS) and duration of viremia compared with 
those of control group. These results suggest that in addition to envelope proteins, 
N protein may also play an important role in inducing host protection. For further 
characterization of these proteins, monoclonal antibodies (MAbs) were prepared. 
Most of the MAbs were found to be against conformationally dependent epitopes. 
Antigenic variation was found in PRRSV field isolates and thirty-three PRRSV 
isolates were divided into three groups based on their reactivity with the MAbs to 
GP2, GPS and M proteins. Eariy virus-cell interactions in PRRSV infection was 
evaluated with a virus binding assay on GRL11171 cells. The recombinant ORFs 2 
to 6 products failed to block PRRSV binding, implying that there were necessary 
interactions between viral structural proteins. PRRSV receptor was shown to 
contain protein moieties as protease treatment of cell monolayers reduced virus 
binding. The receptor activity was reduced from the cell surface with octyl-
glucoside treatment, but no specific protein band was found by 
immunoprecipitation of the cell suri'ace extracts, suggesting that the PRRSV 
receptor is present in low concentration. An 18-kDa viral protein was found to bind 
to the cells by an adsorption assay. Glycosylation did not affect the binding ability 
vii 
of this protein. The protein was immunoprecipitated with MAb against PRRSV M 
protein, suggesting its potential involvement in virus binding and/or entry. 
1 
GENERAL INTRODUCTION 
Porcine reproductive and respiratory syndrome virus (PRRSV) is tlie 
causative agent of porcine reproductive and respiratory syndrome (PRRS), which is 
characterized by severe reproductive failure In sows, respiratory disease in young 
pigs and an influenza-like syndrome in grow/finish pigs (Hill, 1990; Goyal, 1993). 
PRRS has caused heavy economic losses to the swine industry due to abortions, 
stillborn pigs, repeat breeding, pre-weaning and post-weaning mortality, reduced 
feed conversion and increased drug and labor cost, and continues to be the 
number one health challenge in the swine industry since the first cases were 
reported in 1987 (Carlton, 1998). The etiology of PRRS was unknown during the 
first few years and various agents were considered to be the cause of this disease 
(Goyal, 1993). In 1991, Dutch researchers isolated a virus designated as the 
Leiystad virus (LV) by using porcine alveolar macrophages (PAM) (Wensvoort et 
a/., 1991). The LV caused PRRS experimentally and was demonstrated to be the 
causative agent of European PRRS (Pol et ai, 1991, Terpstra et aL, 1991). In the 
United States, the first isolation of PRRSV was accomplished in a continuous cell 
line GL2621 (Benfield et aL, 1992b, Collins et aL, 1992), and the virus was 
subsequently demonstrated to be the causative agent of the U.S. PRRS 
(Christiansen et aL, 1992). The European and U.S. PRRSV have been shown to 
be antigenically and structurally related (Wensvoort etaL, 1992). But It has been 
established that European and U.S. PRRSV strains represent two genotypes and 
there are phenotypic, pathogenic and antigenic variations among PRRSV isolates 
(Drew etaL, 1995, Kapur etaL, 1996, Katz etaL, 1995, Mardassi etaL, 1994a, 
Meng etaL, 1995a, Meng etaL, 1995b, Meng etaL, 1996b, Nelson etaL, 1993, 
Suarez etaL, 1996a). Marked differences in virulence between U.S. and 
European PRRSV isolates as well as among U.S. isolates in experimentally 
infected pigs have also been detected (Halbur et al., 1995 & 1996). 
PRRSV is a small, enveloped RNA virus with a particle size ranging from 50 
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to 80 nm (Benfield etai, 1992b, Wensvoort etaL, 1991). PRRSV is classified in the 
family Arteriviridae which include equine arteritis virus (EAV), lactate 
dehydrogenase-elevating virus (LDV) of mice and simian hemorrhagic fever virus 
(SHFV), in the order Nidovirales (Cavanaugh, 1997). The primary feature of 
members of this order is linear, non-segmented, positive-sense and single-
stranded RNA, and gene order in the genome as replicase gene located at 5'-end 
followed by structural and/or non-structural protein genes. The replication of 
viruses in this order involves the formation of a 3' co-temninal nested set of four or 
more subgenomic mRNAs and only the 5' unique regions of the mRNAs are 
translated (Cavanaugh, 1997). 
The genome of PRRSV is a positive-sense single strand RNA of 
approximately 15 kb in size and contains eight open reading frames (ORFs). The 
ORFs 2 to 4 for U.S. isolate VR2385 have been predicted to encode 29.5, 28.7 and 
19.5 kDa membrane-associated products, respectively (Morozov et al., 1995). It 
has not been directly demonstrated if the ORFs 2 to 4 of U.S. PRRSV isolates 
encode structural proteins though the ORFs 2, 3 and 4 of LV have been found to 
encode virion-associated proteins (GP2, GP3 and GP4) (Meulenberg & Petersen-
Den Besten, 1996, Van Nieuwstadt et al., 1996). The 0RF3 of a Canadian PRRSV 
isolate has been shown to encode a non-structural protein (Gonin et al., 1997). 
The ORFs 5, 6 and 7 of PRRSV were found to encode a glycosylated envelope 
protein (GP5), a membrane (M) protein and a nucleocapsid (N) protein, 
respectively (Mardassi et al., 1995a, Meulenberg et al., 1995). However, due to the 
difficulty of obtaining pure individual proteins from PRRSV particles and the 
shortage of monoclonal antibodies to them, it has been difficult to study functions of 
individual proteins. Thus viral protein(s) responsible for virus attachment has not 
been documented. 
The prevalence of PRRS in swine herds is high. It is estimated that 60-80% 
of herds are infected with PRRSV (Zimmemnan et al., 1997b). One of the essential 
components in an elimination program is to differentiate vaccination from wild type 
PRRSV infection, which is difficult to achieve due to the widespread use of modified 
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live virus and killed virus vaccines and the unavailability of marker vaccines. 
Subunit vaccines can be used as marker vaccines and will be useful in PRRSV 
control and elimination programs. It is not yet known which viral protein(s) induce 
protective immune responses in pigs though it has been reported that GPS and 
GPS are involved in partial protection by immunization of sows (Duran et al., 1997). 
The main target for PRRSV infection in vivo is the porcine alveolar 
macrophage (PAM) (Wensvoort etal., 1991). A few established cell lines have 
been shown to support PRRSV replication in vitro including CL2621 (Benfield et 
al., 1992b, Collins etal., 1992), GRL11171 (Meng etal., 1994) and MA-104 (Kim et 
al., 1993). The mechanism for restriction of PRRSV growth in other cell types is 
speculated to be due to the absence of a virus receptor. The failure of virus binding 
to cells is believed to be the major mechanism for the restriction as all intracellular 
virus replication events occur following virus binding to a cellular receptor. It was 
reported that PRRSV enters cells through a low pH-dependent receptor-mediated 
endocytic pathway (Kreutz & Ackermann, 1996). However, the cell surface 
molecule(s) that serves as virus receptor for PRRSV and other arteriviruses is not 
known. Studies on viral proteins and virus-cell interactions will be useful for further 
studies on viral attachment protein, PRRSV receptor and cell tropism. Valuable 
information will also be gained for understanding of PRRSV pathogenesis, 
structure-function relationships, and antigenic variations, and will contribute to the 
control and prevention strategy of PRRS. 
Dissertation Organization 
This dissertation is organized In an altemate format. It begins with an 
abstract, followed by a general introduction and literature review. Three 
manuscripts include reports of experimental work. The first manuscript "Cell 
surface expression of viral proteins of porcine reproductive and respiratory 
syndrome virus in insect cells and their role in protection against respiratory 
disease" is to be submitted to Vaccine. The second manuscript is "Monoclonal 
antibodies against conformationally dependent epitopes on porcine reproductive 
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and respiratory syndrome virus" and is accepted for publication in Veterinary 
Microbiology. The third manuscript is "Characterization of porcine reproductive 
and respiratory syndrome virus receptor moieties on cell surface of a susceptible 
continuous cell line and detection of an 18 kDa viral protein binding to target cells" 
and to be submitted to Archives of Virology. The fourth manuscript is "Antigenic 
variation in porcine reproductive and respiratory syndrome virus isolates 
determined with monoclonal antibodies to GP2, GP3 and M proteins" and to be 
submitted to Archives of Virology. Yanjin Zhang is the primary author of all the four 
manuscripts. The fourth manuscript is followed by general conclusions, and 
references cited in the general Introduction, literature review and general 
conclusions. The last part is acknowledgments. 
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LITERATURE REVIEW 
History of PRRS 
Outbreaks of a new disease characterized by severe reproductive failure In 
sows and respiratory diseases In young pigs occurred in North Carolina, 
Minnesota and Iowa during 1987-1988 (Goyal, 1993, Hill, 1990). The disease was 
referred to as "Mystery Swine Disease" because of Its unknown etiology (Dial et a!., 
1990, Hill, 1990, Keffaber, 1989, Loula, 1991). By 1990, the disease had been 
detected in 11 states of the United States and 2 provinces of Canada (Hill, 1990). 
In late 1990, It was reported in most western European countries including 
Gennany, Netherlands, France, Belgium, England and Denmark (Goyal, 1993, 
Wensvoort et ai, 1991). As this disease spread throughout the world, various other 
names were given to this syndrome such as disease 89, SMEDI-IIke syndrome, 
swine reproductive failure syndrome, swine reproductive and respiratory syndrome 
(SRRS), swine infertility and respiratory syndrome (SIRS), blue ear disease, Heko-
heko disease and so on (Paul ef a/., 1993). In 1992, participants of the first 
Intemational symposium on the disease in St. Paul, Minnesota, agreed to use 
"porcine reproductive and respiratory syndrome (PRRS)" to name the disease 
(Collins, 1993). Since Its first report In 1987, PRRS has caused heavy economic 
losses to the swine industry due to abortions, stillborn pigs, repeat breeding, pre-
weanlng and post-weaning mortality, reduced feed conversion efficiency and 
increased drug and labor cost. 
Etiologic agent of PRRS 
The etiology of PRRS was unknown In the beginning and various agents 
were considered to be the causative agent of this disease, including 
encephalomyocardltis virus (EMCV), pseudorabies virus (PRV), porcine parvovirus 
(PPV), swine influenza virus (SIV), hemagglutinating encephalomyelitis virus 
(HEV), porcine enterovirus (PEV), porcine cytomegalovirus (PCMV), Chamydia 
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psitacii, Leptospira bratislava, L pomona, and mycotoxins (Benfieid et ai, 1992a, 
Keffaber, 1989). However, none of these agents was proven to be the cause of 
PRRS. 
in 1991, Dutch researchers isolated a virus designated as the Leiystad virus 
(LV) by using porcine alveolar macrophages (RAM) (Wensvoort etaL, 1991). The 
LV caused PRRS experimentally and was demonstrated to be the causative agent 
of European PRRS (Pol etaL, 1991, Terpstra etal., 1991). In the United States, the 
first isolation of PRRSV was accomplished in a continuous cell line CL2621 and 
the isolate was designated as the ATCC VR-2332 (Benfieid etaL, 1992b, Collins et 
al., 1992), and subsequently demonstrated to be the causative agent of the U.S. 
PRRS (Christiansen etal., 1992). The LV and PRRSV have been shown to be 
antigenically and structurally related (Wensvoort etal., 1992). Many other isolates 
of PRRSV have been isolated in the U.S., Canada and European countries and it 
has been established that European PRRSV and U.S. PRRSV strains represent 
two genotypes and that there are phenotypic, pathogenic and antigenic variations 
among PRRSV isolates (Drew etal., 1995, Kapur et al., 1996, Katz et al., 1995, 
Mardassi etal., 1994a, Meng etaL, 1995a, Meng etaL, 1995b, Meng etaL, 1996b, 
Nelson etaL, 1993, Suarez etaL, 1996a). 
PRRSV, EAV, LDV and SHFV were initially placed in the family of 
Togaviridae because they are similar in size and virion structure, but arteriviruses 
have a similar genomic organization and replication strategy to those of 
coronaviruses though arteriviruses have a smaller genome about 13-15 kb in size 
(Conzelmann etaL, 1993, Meulenberg etaL, 1994). During the Xth International 
Congress of Virology, Jerusalem, August 1996, Coronaviridae and Arterividae 
were placed Into a new order, Nidovirales, and Coronaviridae was redefined to 
comprise the genera Coronavirus and Torovirus (Cavanaugh, 1997). No serologic 
cross-reaction was found between PRRSV and the other arteriviruses (Benfieid et 
aL, 1992b, Wensvoort etaL, 1991). The primary feature of members of this order is 
a linear, non-segmented, positive-sense and single-stranded RNA genome. The 
replicase gene is located in the 5'-end followed by structural and/or non-structural 
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protein genes. The replication of the viruses In this order involves the formation of 
a 3' co-terminal nested set of four or more subgenomic mRNAs and only the 5' 
unique regions of the mRNAs are translated (Cavanaugh, 1997). The genomic 
RNA functions as the mRNA for the translation of the replicase gene. Other 
features of the order include an enveloped virion with an integral membrane 
protein which spans the membrane at least three times, 3' polyadenylation of the 
genomic RNA, viral replicase encoded by ORFs 1 a and 1 b and ribosomal 
frameshifting mechanism to translate ORF lb (Cavanaugh, 1997). 
Biochemical and physical properties of PRRSV 
PRRSV is a small, enveloped RNA virus with a particle size ranging from 50 
to 80 nm and has a capsid core of approximately 25 to 35 nm (Benfield et al., 
1992b, Wensvoort etal., 1991). The virus loses infectivity after chloroform 
treatment, demonstrating the presence of a lipid envelope (Benfield et al., 1992b, 
Wensvoort etal., 1991). The buoyant density of PRRSV is about 1.18 g/ml in a 
cesium chloride gradients and 1.18-1.23 g/mi in a sucrose gradients (Benfield et 
al., 1992b, Mardassi etal., 1994b, Meng etal., 1996a, Wensvoort etal., 1991). 
Conflicting reports have been published regarding the hemagglutinating property 
of PRRSV. The virus did not agglutinate erythrocytes from several animal species 
including mice (Benfield etal., 1992b, Wensvoort etal., 1991). In contrast, 
Japanese researchers have reported that PRRSV hemagglutinates mouse 
erythrocytes (Jusa etal., 1996a, Jusa etal., 1997a). This virus is heat labile as it 
was inactivated at 37°C in 24 hrs and at 56°C in 45 minutes (Benfield et al., 1992b, 
Meng et al., 1996a, Wensvoort et al., 1991). However, this virus is stable at 4°C for 
one month and at -70°C for 4 months (Benfield et al., 1992b). The virus is 
inactivated in media with pH lower than 5 and greater than 7 (Benfield etal., 
1992b). 
PRRS virus grows in several cell types including porcine alveolar 
macrophages (PAM) (Wensvoort et al., 1991), the continuous cell lines CL2621 
(Benfield etal., 1992b, Collins etal., 1992), CRL11171 (Meng etal., 1994) and MA-
8 
104 (Kim et al., 1993). PRRSV infection causes cells to round off, clump and lyse 
rapidly in RAM cultures (Wensvoort etal., 1991). Replication of U.S. PRSSV on 
continuous cell lines results in slower development of CPE characterized by 
rounding, clumping and lysis of cells (Benfield etal., 1992b, Meng etal., 1996b). 
Virus replication is restricted in the cytoplasm of infected cells, as demonstrated by 
fluorescent antibody assay (Benfield etal., 1992b, Kim etal., 1993, Meng etal., 
1996b). Swine testis (ST) cells have also been reported to support PRRSV 
replication (Plana etal., 1992). 
Genome organization and replication 
The genome of PRRSV is about 15 kb in length with a similar organization 
and replication mechanism to those of coronavirus (Conzelmann et al., 1993, Meng 
etal., 1994, Meulenberg etal., 1993). Eight open reading frames (ORFs) have 
been identified in the PRRSV genome and these ORFs overlap each other from 1 
base between the ORFs 4 and 5 of LV to 253 bases between ORFs 3 and 4 of LV 
(Conzelmann et al., 1993, Meulenberg etal., 1993). However, for U.S. PRRSV 
isolates, there is a 10-base non-coding region between ORFs 4 and 5 (Meng etal., 
1995b, Morozov etal., 1995). The ORFs la and lb comprise 80% of the viral 
genome and are predicted to encode the viral RNA replicase (Meulenberg et al., 
1993). Ribosomal frameshifting is believed to be the mechanism for ORF lb 
expression as in coronavirus (Meulenberg etal., 1993). The ORFs 2, 3 and 4 of 
PRRSV are predicted to encode membrane-associated proteins with putative N-
linked glycosylation sites (Morozov etal., 1995). The ORFs 5, 6 and 7 have been 
found to encode a major envelope glycoprotein (E), a membrane protein (M) and a 
nucleocapsid protein (N), respectively (Mardassi etal., 1995b, Meulenberg etal., 
1995). 
In PRRSV infected cells, a 3' co-terminal nested set of six or seven 
subgenomic mRNAs are formed (Conzelmann etal., 1993, Meng et al., 1994, Meng 
et al., 1996b, Meulenberg etal., 1993). These subgenomic mRNAs have a 
common 5' leader sequence derived from the 5'-end of genomic RNA and the 
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same 3' temnlnal sequence including a poly-(A) tail. At the beginning of each 
subgenomic mRNA there is a common leader sequence of 221 bases in size for 
Leiystad virus (Meulenberg etal., 1993) and 190 bases for U.S. PRRSV (Morozov 
etal., 1998). These subgenomic mRNAs are polycistronic in structure but it Is 
believed that only the first open reading frame (ORF) of each subgenomic mRNA is 
translated into a viral protein (Meng et a!., 1996b), A small subgenomic mRNA 
named mRNA3-1 with a coding capacity of 45 amino acids was found in cells 
infected with certain PRRSV isolates (Meng etal., 1996b). However, it is not known 
If this small ORF Is translated into a product or has any biological function. 
Two current models are proposed to explain the mechanism of 
discontinuous transcription of subgenomic mRNAs (Lai etal., 1994). One is the 
leader-primed transcription, in which the leader sequence is transcribed from the 3' 
end of the genome-sized negative strand RNA, dissociates from the template, and 
then reattaches to the RNA template at intergenic sequences located downstream 
on the genome RNA and serves as the primer for RNA transcription (Baric et ai, 
1985, Lai et al., 1994), The intergenic sequence is regarded as the promoter 
sequence and the transcription initiation site in this model. The other model 
proposes that a discontinuous transcription step occurs during negative strand 
RNA synthesis and that intergenic sequences serve as transcription stop sites. The 
nascent negative strand RNA jumps to the leader sequence and serves as a 
template for subgenomic mRNA replication (Sawicki & Sawicki, 1990). In both of 
these models, the interaction of the leader sequence and the intergenic sequence 
is crucial for the proper joining of leader to the mRNAs. There is some data to 
support both of these models, but the first one is more accepted currently. 
Viral proteins 
PRRSV ORFs 2 to 7 were predicted to encode viral structural proteins from 
nucleotide sequence studies after the 3'-end of the genome sequence was 
available (Conzelmann etal., 1993, Meulenberg etal., 1993). ORFs 2 to 4 were 
predicted to encode membrane-associated proteins (Meng etal., 1995b, Morozov 
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etai, 1995). ORFs 5 to 7 were predicted to encode envelope protein, membrane 
and nucleocapsid proteins, respectively (Conzelmann etai, 1993, Meng etai, 
1994, Meulenberg etai., 1993). Westem-blot with pig anti-PRRSV serum was used 
later to investigate viral proteins in infected cells and in purified virus particles 
(Meulenberg etai, 1995, Nelson etai, 1993). Three proteins with molecular mass 
(Mr) of 15, 19, and 26 kDa were identified and designated N, M and E protein, 
respectively (Meulenberg etai., 1995, Nelson etai., 1993). The E protein is 
glycosylated and was renamed GPS to reflect its glycosylated nature (Meulenberg 
et al., 1998). It was reported that the ORFs 2 to 4 of LV encode virion-associated 
proteins designated as GP2, GP3 and GP4, respectively (Meulenberg & Petersen-
Den Besten, 1996, Van Nieuwstadt etai., 1996). However, it has not been directly 
demonstrated if U.S. PRRSV ORFs 2 to 4 also encode virion-associated proteins. 
The GP2, GP3 and GP4 proteins 
Nucleotide sequence studies predicted that U.S. PRRSV ORFs 2, 3 and 4 
encode 29.5, 28.7 and 19.5 kDa polypeptides with 2, 7 and 4 potential 
glycosylation sites, respectively (Morozov etai., 1995). GP2 was identified in LV as 
a 29-30 kDa virion-associated glycoprotein with ORF2-specific anti-peptide serum 
in westem-blot (Meulenberg & Petersen-Den Besten, 1996), It was present In 
lysates extracted from virus infected cells and purified virions. It was believed that 
a large amount of virion protein, 10 pg per nitrocellulose strip, made the protein 
detectable. Endoglycosidase F treatment of immunoprecipitated proteins released 
an unglycosylated form of GP2 with Mr of 24 kDa. The 6 kDa difference between 
glycosylated and core proteins suggests that the two potential glycosylation sites 
identified in the amino acid sequence of ORF2 are used in vivo. Endoglycosidase 
H treatment of the immunoprecipitate indicated that the endoglycosidase H-
sensitive N-glycans of GP2 become endoglycosidase H-resistant during passage 
through Golgi compartment in infected cells (Meulenberg & Petersen-Den Besten, 
1996). No other reports are available about PRRSV GP2 protein. In the closely 
related arterivirus, LDV and EAV, ORF2 encodes a virion-associated glycoprotein 
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(DE Vries etaL, 1992, Faaberg & Plagemann, 1995), which folds into three distinct 
nnonomers and a disulfide-linked dimer in EAV (DE Vries et aL, 1995). 
ORFs 3 and 4 of LV have been reported to encode virion structural proteins 
identified in purified virus with monoclonal antibodies (MAbs) in a western-blot 
analysis (Van Nieuwstadt etaL, 1996). GPS was identified to be a 45 to 50 kDa 
glycoprotein and GP4 was identified to be a 31 to 35 kDa glycoprotein. MAbs that 
recognized these two proteins in LV also reacted with recombinant ORFS and 
0RF4 proteins expressed in insect cells. Endoglycosidase F treatment of PRRSV 
virions released core proteins with apparent Mr of 29 and 16 kDa, which are similar 
to the Mr calculated from deduced amino acid sequences for ORFs 3 and 4 
products, respectively. Neutralizing activity was found in MAbs against GP4 protein 
of LV, confirming that it is a structural protein and that part of this protein is exposed 
at the virion surface (Van Nieuwstadt et aL, 1996). The presence of GPS and GP4 
in virions of European PRRSV was confirmed by another report discussing MAbs 
(Wieczorek-Krohmer et aL, 1996). A 30-40 kDa protein and 40-50 kDa protein 
were identified in virions and epitopes of the 30-40 kDa protein were detected on 
the virion surface by immune electron microscopy (Wieczorek-Krohmer et aL, 
1996). However, the ORFS of a Canadian PRRSV reference strain was found to 
encode a non-structural protein (Gonin etaL, 1997). In the closely related 
arterivirus, LDV, ORF 3 was demonstrated to encode a soluble, nonstructural, 
highly glycosylated and antigenic protein (Faaberg & Plagemann, 1997). ORFs 3 
and 4 in EAV genome were believed to encode nonstructural proteins since all 
proteins in the virus preparation were assigned and their in vitro translation 
products were not recognized by the anti-virion serum (DE Vries et aL, 1992). 
The GPS, M and N proteins 
The deduced amino acid sequence studies showed that PRRSV ORFs 5, 6 
and 7 encode 200, 174 and 123 amino acids, respectively, for U.S. PRRSV (Meng 
etaL, 1994) and 201, 173 and 128 amino acids, respectively, for LV (Meulenberg 
etaL, 1993). The predicted Mr of GPS, M and N of U.S. PRRSV are 22.2, 19.1, and 
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13.6 kDa with 2, 1 and 2 potential glycosylation sites, respectively (Meng etal., 
1994). GPS was predicted to be a hydrophobic membrane-associated protein with 
a 32-33 amino acid signal sequence at the amino terminus (Conzelmann et ai, 
1993, Meng etal., 1994, Meulenberg et ai, 1993). 0RF6 contains three putative 
membrane-spanning fragments at the N-terminus and the deduced amino acid 
sequence has a similar hydrophobicity profile to that of M protein of EAV and VP2 
of LDV (Conzelmann etal., 1993, Meng etal., 1994, Meulenberg et a!., 1993). It 
has been suggested that PRRSV M protein has similar membrane topology and 
membrane-associated function as its counterpart in other arteriviruses 
(Meulenberg et al., 1995). In vitro translation in the absence of microsomal 
membranes yielded products of 20 kDa for 0RF5, 18 kDa for ORF6 and 15 kDa for 
ORF7 (Meulenberg et al., 1995). In the presence of microsomal membranes, in 
vitro translation resulted in 25 kDa products for 0RF5 but did not affect the products 
of ORFs 6 and 7, suggesting that GP5 was glycosylated and that M and N proteins 
were not glycosylated (Mardassi et al., 1995a, Meulenberg etal., 1995). 
Endoglycosidase F treatment of virus preparations reduced Mr of GP5 to 17-18 
kDa, confirming that GPS is the glycosylated major envelope protein. The M and N 
proteins were also identified from virus preparations by radioimmunoprecipitation 
and westem blot with peptide specific antibodies (Mardassi et a!., 1995a, 
Meulenberg etal., 1995). 
Pulse-chase experiments were used to study the intracellular transport of 
GPS and found that GPS undergoes a gradual glycosylation change during 
transport through the Golgi compartment (Mardassi etal., 1996). Two differentially 
glycosylated forms of GPS were found to be incorporated into extracellular virions, 
a heterogeneously glycosylated form bearing complex type glycans as well as 
high-mannose oligosaccharides, and the second form containing only complex 
types of carbohydrates (Mardassi etal., 1996). However, linear neutralizing 
epitopes were found on GPS by MAbs with neutralizing activity and were not 
affected by the absence of carbohydrate residues (Pirzadeh & Dea, 1997). This 
result implies that GPS has a role in virus attachment or entry Into target cells and 
13 
that glycosylation is not associated with the neutralizing epitope(s). 
PRRSV GPS and M proteins in virions form heterodimeric complexes linked 
by disulfide bonds similar to their counterparts in EAV and LDV (Mardassi et al., 
1996). In EAV and LDV, 0RF5 products are GL and VPS, and ORF6 products are 
M and VP2, respectively (Chimside, 1992, Plagemann etal., 1992). The products 
of ORFs 5 and 6 in EAV and LDV virions form a heterodimeric complex linked by 
disulfide bond (DE Vries etal., 1995, Faaberg etal., 1995). The disruption of the 
disulfide bond abrogates the viral infectivity, suggesting that the heterodimer plays 
an important role in virus-cell receptor interaction and that the disulfide bond may 
stabilize the virus attachment site (DE Vries etal., 1995, Faaberg etal., 1995). It is 
not known if the PRRSV GP5 and M heterodimer also plays a similar role in virus 
infection. 
Epitopes on the N protein have been mapped through reactivity of MAbs 
with N fragments expressed in E. coli which revealed at least three epitopes, two 
discontinuous and one linear (Rodriguez etal., 1997). The two discontinuous 
epitopes were present in the partially folded protein and in the first 78 residues. 
The linear epitope is located in the central region of the protein and is conserved 
among European and U.S. isolates but the fragment has weak reactivity with pig 
sera (Rodriguez etal., 1997) indicating low immunogenicity of this epitope in pigs. 
Genotypic and antigenic diversity among PRRSV isolates 
Nucleic acid sequence studies indicate that there are two genotypes of 
PRRSV, the European and North American (Kapur et al., 1996, Meng etal., 1995a, 
Meng etal., 1995b, Meng etai., 1994, Morozov etal., 1995). The Japanese and 
other Asian PRRSV isolates are similar to the U.S. PRRSV genetically and 
antigenically (Saito et al., 1996, Shibata etal., 1996). The deduced amino acid 
sequence analysis demonstrated that 0RF6 and ORF7 genes of North American 
PRRSV isolates display only 78-81% and 57-59 % amino acid sequence identity 
with those of European PRRSV, respectively (Meng etal., 1995a). The ORFs 2 to 5 
genes of North American PRRSV isolates share only 57-61%, 55-56%, 65-67% 
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and 51-55% amino acid identity with those of LV, respectively (Meng etal., 1995b). 
These results revealed great differences between isolates from the two continents, 
suggesting that there are two distinct genotypes. Antigenic studies with MAbs 
showed consistent antigenic differences between North American and European 
PRRSV isolates (Drew etaL, 1995, Magar etal., 1997, Nelson etal., 1993, 
Pirzadeh & Dea, 1997), 
There is also genetic and antigenic diversity among North American PRRSV 
isolates as well as among European isolates. The deduced amino acid sequence 
of M and N genes displayed 96-100% identity among eight U.S. isolates with 
different virulence (Meng et al., 1995a). The amino acid sequence identity among 
U.S. isolates with different virulence is 95-99% in ORF2, 90-98% in 0RF3, 94-98% 
in 0RF4 and 88-97% in 0RF5 (Meng etal., 1995b). One low virulent isolate, 
ISU3927, shares low amino acid sequence identity with other isolates, 91-93% in 
ORF2, 86-88% in ORF3, 92-93% in ORF4 and 89-92% in ORF5 (Meng etal., 
1995b). Among ORFs 2 to 7 genes of PRRSV, ORF5 is the most polymorphic and 
ORF6 Is the most consen/ed (Kapur etal., 1996, Meng etal., 1995a, Meng etal., 
1995b). Statistical analysis of nucleotide sequence data indicates intragenic 
recombination or gene conversion in ORFs 2, 3, 4, 5 and 7 (Kapur et al., 1996). For 
European isolates, genetic and antigenic diversity was also described (Gall et al., 
1997, Suarez etal., 1996b). The nucleotide and amino acid identities among 
isolates from different European countries were 94.1-99.6% and 95.3-100% In 
ORF7, respectively, and 87.1-99.2% and 88% in ORF5, respectively, (Suarez etal., 
1996b). 
The different reactivity of MAbs with PRRSV isolates confirmed the existence 
of two genotypes, European PRRSV and North American PRRSV (Drew etal., 
1995, Magar etal., 1997, Nelson etal., 1993, Pirzadeh & Dea, 1997, Wleczorek-
Krohmer et al., 1996). Two MAbs to N protein recognized a conserved epitope in 
U.S. and European PRRSV isolates but four other MAbs to N protein reacted with 
U.S. isolates only (Nelson etal., 1993). Six MAbs raised against a British isolate of 
PRRSV did not react with U.S. isolates, indicating a consistent antigenic difference 
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between the two genotypes (Drew etai, 1995). Five MAbs against GPS protein of 
a Canadian isolate did not react with LV (Pirzadeh & Dea, 1997). A MAb to M 
protein reacted with all 148 North American PRRSV isolates tested but failed to 
react with any of the 13 isolates from Europe including LV (Magar etal., 1997). The 
reactivity of MAbs against GPS, GP4 and N proteins with European and American 
PRRSV isolates revealed antigenic differences between the two genotypes and 
among different European or U.S. Isolates, respectively (WIeczorek-Krohmer etai, 
1996). Serological analysis of a recombinant GPS protein revealed antigenic 
differences between European and American isolates (Katz etai, 1995). 
Variability between an isolate and its progeny recovered after one or two passages 
in vivo was found and restricted to GPS protein (Gall etai, 1997). However, the 
Importance of the antigenic variability in PRRSV pathogenesis and host immune 
response needs further investigation. 
Epidemiology 
The eariiest reported clinical outbreaks of PRRS were In the midwest U.S. In 
1987 (Hill, 1990), Since then PRRS has spread rapidly through swine populations 
in Europe, North America and Asia (Bautlsta eta!., 199Sc, Chang etai., 199S, 
Wensvoort et al., 1992). Retrospective surveys showed that the first positive cases 
of PRRS based on serologic testing (IFA) occurred In Iowa in 1985 (Owen et al., 
1992) and in Minnesota in 1986 (Joo etal., 1992). The Incidence of PRRS 
reportedly increased rapidly in 1988 and 1989 (Benfield et al., 1992a) as indicated 
from serological surveys based on a pilot National Animal Health Monitoring 
System (NAHMS) study carried out in Iowa from 1985 through 1989 (Hill etal., 
1992). By 1990, PRRS had been reported In 19 states in the U.S. based on clinical 
signs (Zimmerman & Johnson, 1991) and 82.7% of herds from 87 farms In 18 
states were tested seropositive in 1990 (Bautlsta et al., 1993a). The prevalence of 
infection is high In swine herds. It is estimated that 60-80% of herds are infected 
though clinical signs are variable among different farms (Zimmerman etal., 1997b). 
These data are suggestive of a high transmisslbility of PRRSV. 
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The predominant route of PRRSV transmission is direct contact between 
infected and naive pigs although transmission by intranasal route has also been 
demonstrated (Christiansen et al., 1992, Collins etal., 1992, Halburefa/., 1995b, 
Terpstra etal., 1991). Transmission can occur sometimes when susceptible pigs 
are not in direct contact with the Infected pigs (Wills et al., 1997a). It is reasonable 
to expect aerosolization of virus to occur as PRRSV is present in the upper 
respiratory tract and oropharyngeal area of infected pigs. However, there is no 
direct evidence of aerosol transmission and airborne transmission is extremely 
difficult to demonstrate experimentally (Wills etal., 1994). Transmission by direct 
contact between persistently infected and susceptible pigs has been documented 
(Albina etal., 1994, Zimmerman etal., 1992). Shedding of PRRSV in semen has 
been detected in infected boars for as long as 57 days after exposure (Shin et al., 
1997) and artificial insemination of gilts with PRRSV contaminated semen results in 
seroconversion of gilts (Swenson etal., 1994, Yeager et al., 1993). 
PRRSV is a fairly labile virus. It was recovered only on day-0 samples of 
swine saliva, urine and feces, alfalfa, wood shavings, straw, plastic, boot rubber 
and stainless steel (Pirtle & Beran, 1996). But virus was isolated from city water 
through day 11 and from well water through day 9 (Pirtle & Beran, 1996), indicating 
that contaminated water could serve as a source of virus to infect susceptible pigs. 
The route of excretion and duration of shedding of this virus was studied in 
experimentally Infected pigs (Wills etaL, 1997b). PRRSV was isolated in porcine 
alveolar macrophages for up to day 14 from urine, day 21 from serum, day 35 from 
endotracheal tube rinse, day 42 from saliva and day 84 from oropharyngeal 
samples. Virus isolation was negative from conjunctival swabs and fecal samples 
(Wills etal., 1997b). Hence, slurry should be considered as a source of infection, at 
least as a source to contaminate water, especially when slurry is used as fertilizer 
in the vicinity of susceptible herds (Wills etal., 1997b). 
PRRSV can infect avian species. PRRSV was isolated from feces of mallard 
duck and guinea fowl after exposure to PRRSV in drinking water (Zimmemnan et 
al., 1997a). Virus isolation was positive from feces of mallard duck until day 25 
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after exposure and from intestinal contents, but no gross or microscopic lesions 
were observed. Fecal shedding of PRRSV was detected from mallard ducks 
exposed to feces of infected mallard ducks. Exposure of pigs intranasally to 
PRRSV isolated from mallard ducks resulted in viremia, seroconversion and 
transmission to sentinel pigs (Zimmerman etaL, 1997a). 
No other vectors have been documented to be involved in PRRSV 
transmission. There is no reported human infection or illness caused by PRRSV 
and no reports of rodent or insect transmission. 
In late 1996, an abortion and mortality syndrome affected sows in southeast 
Iowa. This has been referred to as "hot" PRRS, SAMS (sow abortion and mortality 
syndrome), atypical PRRS and other names (Epperson & Holler, 1997, Halbur & 
Bush, 1997). Later, it was agreed to use acute PRRS to describe the outbreak. 
The predominate feature was that abortion happened in more than 10% sows at all 
stages of gestation, and that the syndrome usually lasted for 2-4 weeks in a single 
herd. High fever was observed in sows and in some herds over 5% of the infected 
sows died. There was an increase in the mortality rate of pigs bom during the 
epizootic. Studies indicate that PRRSV is at least partly responsible for acute 
PRRS (Lager et al., 1998). It seems that a new, more virulent form of PRRS 
appeared and caused sow death, which is unusual in classic PRRS. However, 
another agent(s) may be involved in the acute PRRS and this has not been 
excluded. Most of the herds affected had been vaccinated with modified live 
vaccine (Epperson & Holler, 1997, Halbur & Bush, 1997). The acute PRRS 
dissipated almost suddenly, but appeared again during last fall and winter all over 
the U.S. (Bell, 1998). 
Pathogenesis 
The pathogenesis of PRRSV has been studied in pregnant sows and in 
conventional and gnotobiotic pigs. The first evidence that PRRS was caused by an 
infectious agent was from a study to reproduce the disease in gnotobiotic pigs with 
filtered homogenate of tissues from affected piglets from PRRS positive herds 
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(Collins et ai, 1991). Clinical signs and production loss vary among herds and 
depend on the health status and complications with secondary infections 
(Christiansen & Joo, 1994). Typical clinical signs seen in acute disease of 
classical PRRS include inappetence, lethargy and depression, and pyrexia. 
Respiratory signs may or may not be observed in adult pigs but are usually 
prominent in young pigs, mainly labored breathing, coughing and sneezing. In 
pregnant sows, premature farrowing, increased stillborn, mummified, and 
weakbom pigs, and increased preweaning mortality are generally observed 
(Goyal, 1993, Hill, 1990). In boars PRRS causes diminished libido, and decreased 
semen volume and quality in addition to the typical clinical signs described above 
(Shin etaL, 1997, Yeager etai, 1993). Virus shedding in semen is reported to last 
up to 57 days post challenge and abnormalities in sperm were observed in the 
form of proximal droplets and abnomnal tails at 36-50 days post-challenge (Shin et 
al., 1997). 
Gross lesions of PRRSV infection have been described, which vary widely 
with the different virus isolates used (Christiansen etaL, 1993, Cooper etaL, 1997, 
Halbur et a!., 1995b, Halbur et aL, 1996b, Lager & Mengeling, 1995, Park etaL, 
1996, Rossow etaL, 1995). Lung lesions are multifocally distributed and may be 
locally intensive. Alveolar septa are thickened by infiltration of mononuclear cells, 
especially macrophages. Dead cells and cell debris can be observed in alveolar 
spaces. Interstitial pneumonia is the most common form of lung lesion reported in 
both experimentally and naturally infected pigs. Lymphoid tissue lesions are found 
in multiple sites and are characterized by germinal center hypertrophy and 
hyperplasia, and germinal center necrosis. Vascular lesions in the blood and 
lymphoid vessels have been described as infiltration of lymphocytes, macrophages 
and plasma cells, and heart lesions and brain lesions include infiltration of 
lymphocytes in infected pigs (Christiansen etaL, 1993, Halbur et aL, 1995b, Halbur 
etaL, 1996b, Rossow etaL, 1996, Rossow etaL, 1995). 
Replication of PRRSV has been studied in young pigs to determine location, 
duration and cellular targets of infection. PRRSV was detected in alveolar 
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macrophages and lung until 35 days post-inoculation (DPI), in tonsils, spleen and 
bronchial lymph nodes until 14 DPI, but not in heart, peripheral blood mononuclear 
cells and bone marrow cells (Duan etaL, 1997). Viremia was detected from 3 to 28 
DPI and fewer than 2% alveolar macrophages were found to be PRRSV positive. 
Macrophages are the main target cells for PRRSV infection as 80-94% of infected 
cells in the lung were macrophages and all infected cells in lymph nodes and 
spleen were macrophages (Duan et aL, 1997). In another study with ATCC VR-
2332, PRRSV antigen was detected at 12 hour after exposure in bronchiolar 
epithelial cells, arteriolar endothelial cells, monocytes, and interstitial, alveolar, and 
intravascular macrophages (Rossow etaL, 1996, Rossow etaL, 1995). In lung 
sections, PRRSV antigen was detected in endothelial cells, monocytes, and 
alveolar, interstitial, and intravascular macrophages at 14 and 21 DPI. In the heart, 
interstitial macrophages and endothelial cells in a few arterioles were found to be 
positive for PRRSV antigen at 14 and 21 DPI. It was concluded that PRRSV 
Infection starts after Initial virus entry through nasal epithelial, tonsillar, and 
pulmonary macrophages, causes viremia by 12 hour after exposure and results in 
pneumonia, myocarditis, encephalitis, rhinitis, vasculitis and lymphadenopathy 
(Rossow etaL, 1996, Rossow etaL, 1995). 
Transplacental infection in pregnant sows was demonstrated after intranasal 
infection with PRRSV (Christiansen etaL, 1993, Christiansen etaL, 1992, Dea et 
aL, 1992, Terpstra etaL, 1991). PRRSV was isolated from llvebom or stillbom 
piglets, but not from mummified fetuses. Viremia was detected in infected sows as 
eariy as I DPI and was prolonged up to 14 days. It is not known how the virus 
crosses placenta and infects fetuses. It is suggested that infected macrophages 
migrate across the placenta (Terpstra et aL, 1991), but the mechanism has not 
been demonstrated to be necessary as viremia can last for two weeks in infected 
sows. It was demonstrated that transplacental infection occurred more likely when 
pregnant females were exposed to PRRSV in the third stage of gestation than in 
the first two stages of gestation (Mengeling etaL, 1994). 
It has been observed that there are marked differences in virulence between 
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U.S. and European PRRSV strains as well as among U.S. isolates in 
experimentally Infected pigs (Halbur etaL, 1995b, Halbur ef a/., 1996b). LV and a 
low virulent U.S. PRRSV isolate VR2431 induced mild transient pyrexia, dyspnea 
and tachypnea, but several high virulent isolates including VR2385 induced 
labored respiration, pyrexia, lethargy, anorexia and patchy demial cyanosis. At 10 
DPI, mean lung lesion scores estimating the percentage of lungs affected by 
pneumonia ranged from 6.8% for LV, 9.7% for VR2431, 54.2% for VR2385, to 
62.4% for ISU-28 (Halbur etaL, 1995b, Halbur etaL, 1996b). These studies 
demonstrated marked differences in pathogenicity among different field isolates. 
The different ability to cause reproductive failure has also been demonstrated for 
different isolates. The number of dead fetuses from PRRSV-infected gilts ranged 
from 0 for four gilts exposed to the vaccine strain, to 38 for four gilts exposed to a 
virulent strain (Mengeling ef a/., 1996a). The difference in virulence may be helpful 
to explain variable clinical signs among different herds. 
The ability of PRRSV to replicate in macrophages and its potential 
immunosuppression effect on host immune defense led to research on the effect of 
dual infections with PRRSV and other infectious agents, including Streptococcus 
suis , Haemophilus parasuis, Pasteurella multocida, Actinobacillus 
pleuropneumoniae, HI N1-influenza virus, and porcine respiratory coronavirus 
(PRCV) in pigs (Carvalho etaL, 1997, Galina etaL, 1994b, Park & Joo, 1997, Pol et 
aL, 1997, Solano etaL, 1997, Van Reeth etaL, 1996, Van Reeth & Pensaert, 1994). 
A combined infection with PRRSV followed by Streptococcus suis one week later 
induced central nervous disorders and suppurative meningitis (Galina eta!., 
1994a, Galina etaL, 1994b). However, no clear interaction between PRRSV and 
Pasteurella multocida or between PRRSV and Haemophilus parasuis was 
demonstrated experimentally (Carvalho etaL, 1997, Solano etaL, 1997). Dual 
virus infections of PRRSV followed 3 days later by PRCV or HI N1-influenza virus 
caused more severe disease and growth retardation than with any of the single 
infectious agents above (Van Reeth etaL, 1996, Van Reeth & Pensaert, 1994). 
Mycoplasma hyopneumoniae can act as a cofactor in potentiating PRRSV-induced 
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pneumonia (Thacker et aL, 1998). The mechanism of severe disease caused by 
dual infections remains to be elucidated. 
PRRSV has been demonstrated to cause persistent infection in 
experimentally Infected pigs (Albina etaL, 1994, Bilodeau et aL, 1994, Halbur et aL, 
1995b, Halbur etaL, 1996b, Rossow etaL, 1996, Rossow etaL, 1995, Terpstra et 
aL, 1991, Wills etaL, 1997b, Yoon etaL, 1993). PRRSV RNA was isolated by PGR 
at 92 DPI from the semen of boars experimentally infected with PRRSV 
(Christopher Hennings etaL, 1996, Christopher Hennings etaL, 1995a). PRRSV 
naive pigs became infected with the virus after direct contact with pigs persistently 
infected with PRRSV at 22 weeks after infection (Albina etaL, 1994). Virus 
isolation was positive from oropharyngeal samples up to 157 DPI but only up to 23 
DPI from serum (Wills etaL, 1997b). The pathological significance of PRRSV 
persistence Is not clear, but the presence of pigs persistently infected with PRRSV 
is an important factor for PRRSV survival and transmission. 
PRRSV infection can induce apoptosis in vivo and in vitro (Sirinarumitr et aL, 
1998, Suarez et aL, 1996a, Sur etaL, 1997). PRRSV 0RF5 product expressed in a 
vaccinia virus expression system induced apoptosis in infected cells as indicated 
by nucleosome ladder formation, chromatin condensation, and rRNA degradation, 
and the apoptosis could not be prevented in a cell line expressing Bcl-2 protein 
(Suarez etaL, 1996a). In PRRSV infected boars, the virus-induced apoptosis has 
been detected in germ cells (Sur etaL, 1997). Apoptosis was also detected in the 
lungs and lymph nodes of infected pigs and in continuous cell lines Infected with 
PRRSV (Sirinarumitr etaL, 1998). Interestingly, the cells undergoing apoptosis 
have been found to be bystander cells (Sirinarumitr et al., 1998). The induction of 
apoptosis by PRRSV infection may be significant in PRRSV pathogenesis and may 
explain the basis of the increased susceptibility of virus infected pigs to secondary 
infections. 
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Virus-cell interactions 
Virus-cell receptor interaction Is the first step of viral infection, followed by 
penetration, uncoating, genome expression and replication, assembly of virus 
particles and exit from the infected cells. The initial attachment is an important 
factor in determining cell tropism and resulting pathogenesis in susceptible host. 
The potential practical significance of virus receptors is the rational dnjg design to 
inhibit virus-cell interaction for therapeutic treatment of virus diseases (Norkin, 
1995). 
PRRSV replicates in several cell types including porcine alveolar 
macrophages (RAM) (Wensvoort etai, 1991), the continuous cell lines CL2621 
(Benfield etai, 1992b, Collins etai, 1992), CRL11171 (Meng etai, 1994) and MA-
104 (Kim etaL, 1993). However, It has not been demonstrated which cell surface 
molecule(s) is the virus receptor for PRRSV or for other arteriviruses. It is unclear if 
the virus receptor on primary macrophages is the same receptor as on pennissive 
continuous cell lines. It is also unclear which viral protein(s) is virus attachment 
protein(s). Envelope proteins, by virtue of their location on the surface of virions, 
mediate at least two important functions, binding to receptors on the host cells and 
stimulating host immune response. PRRSV GP4 and GPS proteins have surface 
epitopes and some of the monoclonal antibodies against these two proteins have 
been shown to have neutralizing activity (Kreutz & Ackermann, 1996, Pirzadeh & 
Dea, 1997, Van Nieuwstadt etaL, 1996), Hence, GP4 and GPS are potential 
receptor binding proteins. However, GP2, GP3 and M proteins are also membrane 
proteins and might be involved in virus receptor binding or entry. 
Heparin has been reported to inhibit PRRSV replication when added to 
PRRSV or to the MARC-145 cells prior to inoculation and the treatment of cells with 
heparinase to remove heparin prevented PRRSV infection (Jusa et ai, 1997b). 
However, no other reports are available about the involvement of heparin or 
heparinase in PRRSV or other arterivirus infection, and heparin or heparinase had 
no effect at all on binding or replication of U.S. PRRSV VR2385 (personal 
observation). It has been demonstrated that PRRSV enters cells through a low pH-
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dependent endocytic pathway (Kreutz & Ackermann, 1996). The acidotropic weak 
bases, chloroquine and ammonium chloride, which raise pH of acidic organelles, 
are disrupting endosomal function and preventing dissociation of receptor-ligand 
complexes (Marsh & Helenius, 1989), inhibited PRRSV replication and production 
of infectious virus In a dose-dependent manner (Kreutz & Ackennann, 1996). The 
mechanism of PRRSV penetration is not clear. 
Immune response 
The humoral immune response to PRRSV has been investigated by 
detecting anti-PRRSV antibodies by various serological tests including indirect 
immunofluorescence assay (IFA), enzyme-linked immunosorbent assay (ELISA), 
immunoperoxidase monolayer assay (IPMA) and serum virus neutralization test 
(SVN). Anti-PRRSV IgM antibodies were detected as early as 5 DPI and anti-
PRRSV IgG antibodies were detected between 7 to 10 DPI (Albina et ai, 1994, 
Christlanson etal., 1993, Christiansen etal., 1992, Park etal., 1995, Rossow etal., 
1994, Stevenson etal., 1994a, Yoon etal., 1992b, Yoon eta!., 1994a, Yoon etai, 
1995, Yoon etal., 1996). Anti-PRRSV neutralizing antibodies were detected from 9 
to 105 DPI (Christiansen etal., 1992, Lager & Ackermann, 1994, Stevenson etal., 
1994a, Yoon etal., 1995). Specific antibodies detected by IFA, ELISA, IPMA and 
SVN reached their maximum values by 28-35, 35-42, 28-42 and 77-84 DPI, 
respectively, and were projected to decay by approximately day 137, 158, 324 and 
356 post-infection, respectively (Yoon etal., 1995). Specific IgM antibodies 
decayed from peak level at 14-21 DPI to undetectable level at 35-42 DPI (Loemba 
etal., 1996). Western immunoblot analysis revealed N-protein specific antibodies 
by 7 DPI and antibodies to GPS and M proteins were detected by 9 to 35 DPI, 
which persisted through 105 DPI (Yoon etaL, 1995). In another study, GPS specific 
antibodies were detected at 7 DPI, but antibodies to M and N proteins appeared by 
14 DPI (Loemba et aL, 1996). Persistent viremla was observed and no correlation 
was found between neutralizing antibodies and viremia, neutralizing antibodies 
and viral protein specificities at various time post-infection (Loemba etal., 1996). 
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These results Indicate that serum neutralizing antibodies are not necessarily an 
essential part of the immune response against PRRSV. 
Colostral anti-PRRSV antibodies persisted in the absence of PRRSV 
Infection for 6 to 10 weeks (Houben etaL, 1995b, Stevenson et al., 1994a). Fetal 
pigs can develop anti-PRRSV antibodies in response to Infection (Mengeling et al., 
1996a, Park etaL, 1996). 
It has been demonstrated that PRRSV replication can be enhanced by the 
presence of anti-PRRSV antibodies through Fc-receptor uptake (Christianson et af., 
1993, Yoon et al., 1996, Yoon etal., 1994b). The antibody-dependent 
enhancement (ADE) effect of anti-PRRSV antibodies was shown in vitro on PAM 
cells and in vivo, and virus replication was Increased in the presence of sub-
neutralizing amount of antibodies (Yoon et al., 1996). The antibodies causing this 
enhancement were speculated to be against GPS protein (Yoon et al., 1996). ADE 
can be significant in PRRSV pathogenesis because macrophages are the main 
target for PRRSV replication in pigs and can engulf virus-antibody complexes 
through the Fc receptor. 
The concurrent existence of anti-PRRSV antibodies, viremla, and ADE 
suggest that cell-mediated immunity play an important role in a protective response 
against PRRSV (Molltor etal., 1997, Rossow etal., 1995). Antigen-specific 
lymphocyte proliferation subsequent to PRRSV infection was first detected at 28 
DPI, peaked at 49 DPI, and declined after TI DPI (Bautista & Molltor, 1997). The 
secondary response of T-cell proliferation to PRRSV increased in magnitude. The 
CD4'' T-cells were found to be the major effector cells in the proliferation response 
(Bautista & Molltor, 1997). Pigs infected with PRRSV and challenged intradermally 
with UV-lnactivated virus developed a dose-dependent delayed-type 
hypersensitivity response (DTH) with lesions at the sites of inoculation (Bautista & 
Molitor, 1997). 
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Diagnosis of PRRS 
PRRS diagnosis can be based on typical clinical signs and lesions, 
seroconversion or presence of PRRSV by virus isolation, IFA, 
immunohistochemistry, in situ hybridization or reverse transcription and 
polymerase chain reaction (RT-PCR). Because many infections are mild or 
inapparent, it is difficult to make a diagnosis on the basis of clinical signs. Variable 
signs from pig to pig and from farm to farm and secondary bacterial infections can 
complicate the diagnosis. However, PRRS should be suspected when there is an 
outbreak of respiratory distress in a herd, and during a 14-day period the number of 
abortions and/or premature farrowing are more than 8%, stillboms more than 20% 
or mortality of piglets in the first week of life more than 25% (Christiansen & Joo, 
1994). At necropsy, gross lesions are not observable in most uncomplicated PRRS 
virus infections, and, if any, are confined to lung and enlarged lymph nodes 
(Collins etal., 1992, Halbur etal., 1996a, Halbur etal., 1995b, Halbur ef a/., 1996b, 
Pol et aL, 1991). Histologic examination will reveal lesions characterized by 
interstitial pneumonia with thickened alveolar septa. For histopathology, brain, 
heart, lung, spleen, lymph nodes and nasal turbinate are good samples (Collins et 
aL, 1992, Halbur et aL, 1996a, Halbur etaL, 1995b, Halbur etaL, 1996b, Pol etaL, 
1991). 
The presence of anti-PRRSV antibodies in a herd not vaccinated with 
PRRSV vaccine indicates exposure. A rise in antibody titers in paired sera at 3 
weeks interval, the presence of antibodies in fetal fluids or precolostral blood of 
stillborn and weak pigs are also an suggestion of PRRS. Because PRRS is 
widespread, detection of antibody alone is not evidence for virus as the cause of 
clinical problems. Testing paired sera and sera from different age groups in a herd 
can help determine whether PRRSV is causing an acute infection. The 
seroprevalence based on IFA testing is less than 15% in sow herds 1-2.5 years 
after reproductive failure, but is over 85% in the finishing pigs of the same herds 
(Stevenson etaL, 1994b). Sampling of 30 animals will give 95% confidence for 
detecting a 10% or higher seroprevalence (Dea etaL, 1992). Blood samples 
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should be collected from at least 30 animals in sow herds for diagnosis. For 
finishing pigs ten blood samples will provide 95% confidence for detection in a 
herd with 30% or higher seroprevalence (Morrison etal., 1992a). 
Antibodies in serum samples can be detected by IFA, IPMA, ELISA and SVN 
test. IFA and IPMA can be performed with PAM, CL2621, CRL11171, or MA104 
cell cultures (Bautista etal., 1993b, Wensvoort etal., 1991, Yoon etal., 1992a, 
Yoon et a!., 1992b). Both of these tests are specific, 75% of 165 sows from clinical 
PRRS cases were tested positive by IPMA (Wensvoort et a!., 1991), 75% of 344 
sera from 15 farms with a clinical history of PRRS were positive by IFA and 99% of 
376 sera from herds with no history of PRRS were negative (Yoon et ai, 1992b). 
IFA is one of the most common tests used In U.S. The IPMA Is used commonly in 
Europe. Both of these tests can detect antibodies to PRRSV as eariy as 5 DPI 
(Albina etai, 1994, Christiansen eta!., 1993, Christiansen etal., 1992, Park et a!., 
1995, Rossow etal., 1994, Stevenson etal., 1994a, Yoon etal., 1992b, Yoon etal., 
1994a, Yoon et a!., 1995, Yoon et a!., 1996). Detection of IgM antibodies with IFA 
may indicate a recent infection of PRRSV as IgM antibodies can be detected 
between 5 and 28 DPI and concurrently with viremia, and reinoculation causes a 
brief increase of IgM antibody (Joo etai, 1997, Pari< etal., 1995). However, IFA is 
more sensitive than IPMA for the detection of PRRSV antibodies in colostrum 
(Eichhom & Frost, 1997). 
SVN test is performed on susceptible continuous cell lines in a microtiter 
plate (Frey etal., 1992, Morrison etal., 1992b, Takikawa etal., 1997, Yoon etal., 
1994a). Because the presence of Fc-receptors on PAMs, the SVN test can not be 
carried out in PAMs as the complex of antibody-virus will cause ADE. Neutralizing 
antibodies develop slower and show lower titers than IFA antibodies (Frey etal., 
1992). SVN test was modified to improve its sensitivity and can detect neutralizing 
antibodies earlier and higher (Jusa et al., 1996b, Takikawa et al., 1997, Yoon etal., 
1994a). Yoon et al (1994) obtained higher neutralizing antibody titers consistently 
by the addition of 20% pig fresh serum to the diluted virus and by use of continuous 
cell line MARC-145. SVN antibodies were first detected at 9-11 DPI and declined 
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from a peak at 11-21 DPI. A second peak was detected at 41-45 DPI. The first 
peak is mainly due to IgM and the second is due to IgG antibodies based on the 
sensitivity to 2-mercaptoethanol (Yoon etal., 1994a). The SVN test can 
differentiate different PRRSV isolates as the neutralizing antibody titer was higher 
with homologous PRRSV isolate than with heterologous isolates (Yoon ef a/., 
1994a). In another study, 20% guinea pig fresh serum was added to detect slow-
reacting and complement-requiring neutralizing antibodies as eariy as 8 DPI and 
the serum-virus mixture was incubated at 4°C for 48 hours before addition of 
complement and incubation for one hour at 37°C (Takikawa etal., 1997). The use 
of fresh serum makes this test laborious and unsuitable for routine diagnosis. 
An ELISA kit (HerdChek-PRRSV, IDEXX Laboratories Inc., Westbrook, ME) 
has been widely used to detect PRRSV antibodies (Collins eta!., 1996). The 
ELISA can detect PRRSV antibodies at 9-13 DPI (Collins ef a/., 1996). Compared 
with IFA and IPMA, the ELISA has a similar specificity but is more sensitive (Cho et 
al., 1997), and is much better in terms of time, cost, automation, and capability to 
test a large number of serum samples. A blocking ELISA was developed and is 
more sensitive than IPMA in testing of field sera (Houben et al., 1995a). The 
blocking ELISA has no background problems and is superior to indirect ELISA or 
IPMA in detecting antibodies at eariy or late stage infection (Houben etal., 1995a, 
Sorensen etal., 1997). 
PRRSV antigens in frozen sections or formalin-fixed tissues can be detected 
with immunogold, silver staining, or immunoperoxidase staining (Halbur et al., 
1994, Halbur etal., 1995a, Magar etal., 1993, Pol etal., 1991). Immunogold silver 
staining was reported to be rapid, simple and cheaper than immunoperoxidase 
staining systems in detection of PRRSV antigen in formalin-fixed tissues 
(Larochelle & Magar, 1995). However, these techniques are not widely used and 
are mainly used In research laboratories. A direct FA test is most commonly 
applied to frozen lung sections with the fluorescein-conjugated MAb SDOW17 and 
is an economical and specific test used routinely in PRRSV diagnosis (Collins et 
al., 1996). 
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PRRSV can be isolated from serum and tissues including lung, lymphoid 
tissue, spleen, thymus, tonsil, heart, liver, kidney and brain in infected pigs (Pol et 
ai, 1991, Wensvoort et a/., 1991). A weak pig or an acutely infected pig with 
respiratory signs in the farrowing house is a good candidate for virus isolation (Pol 
etaL, 1991). The virus can be isolated from lungs, serum, plasma, and buffy coat 
cells for 6-8 weeks after infection (Ohiinger et ai, 1992, Pol et al., 1991). Autolyzed 
and mummified fetuses are not suitable for virus isolation (Christianson et al., 
1992). Tissues for virus isolation must be kept refrigerated or frozen. 
The virus can be propagated In PAM or susceptible cell lines including 
CL2621, CRL11171 and MARC-145 cells, but PAM appears to be the most suitable 
for isolation of many isolates (Bautista et al., 1993b). PAM is more sensitive for 
virus isolation as of the 73 serum samples tested for virus isolation, 18 were 
positive in PAM of which only 2 were positive in CL.2621 cells. Fifty-seven out of 82 
isolates grown on CL2621 cells were positive in PAM cells, but 28 out of 57 
isolates grown in PAM were positive in CL.2621 cells (Bautista et al., 1993a). 
However, the failure of certain isolates to grow in PAM indicates that both the PAM 
and established cell lines should be used for virus isolation. Mengeling et al 
(1995) cultured PAMs flushed from Infected lung and detected viral antigen by !FA 
as early as 1 hour after putting the cells to culture vessel. PAMs from infected pigs 
were more reliable than serum, lung or any of 27 other tissues evaluated as 
diagnostic samples and were often the only samples for virus isolation and antigen 
detection after 21 DPI (Mengeling et al., 1995). Cocultivation with MARC-145 cells 
Is the most sensitive method for testing PAMs from infected pigs and virus can be 
detected as long as 63 DPI, compared with 28 DPI from serum (Mengeling et al., 
1996b). 
In herds vaccinated with modified live PRRSV vaccine, the vaccine virus 
may be shed and can be isolated. The vaccine virus may coexist with PRRSV field 
isolates and grows as well or better in cell culture systems (Rossow, 1998). 
Therefore, PRRSV isolates must be differentiated from vaccine virus by either 
restriction enzyme analysis (Wesley etal., 1996) or by reactivity pattem with MAbs. 
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Sequencing ORFs 4 and 5 of PRRSV isolates is another method to differentiate 
field isolates from the vaccine virus as GP4 and GPS proteins are envelope 
proteins and these ORFs are least conserved among different isolates. 
Detection of viral RNA is also an evidence of PRRSV exposure and may be 
more sensitive than virus isolation. RT-PCR has been used to detect viral RNA 
from serum, tissue or semen samples (Carlton, 1995, Christopher Hennings et al., 
1995b, Mardassi etal., 1994b, Suarez et al., 1994, Woensel etai, 1994) and in situ 
hybridization has been used to detect viral RNA in formalin-fixed tissue sections 
(Haynes etal., 1997, Larochelle & Magar, 1997, Larochelle etal., 1996, Sur etal., 
1996). RT-PCR with primers located in ORF6 was able to detect about 30 
infectious units of PRRSV resolved in tissue culture medium or sperm and was 10 
times more sensitive than virus isolation in PAM cells for the detection of PRRSV in 
sperm (Woensel etal., 1994). The maximum sensitivity of RT-PCR with primers 
from ORF7 was 6.7 TCIDgo in infected PAM and about 10^ TCIDgo in crude clinical 
samples from experimentally infected 3-week old pigs (Suarez etal., 1994). RT-
PCR was used to differentiate Canadian and European strains of PRRSV with 
specific primers from 0RF7 and its sensitivity was about 5 TCIDgo, similar to virus 
isolation in PAM but higher than that of IFA (Mardassi et al., 1994b). For the 
detection of PRRSV in samples with reduced virus infectivity or in semen samples, 
RT-PCR has been shown to be better than virus isolation (Carlton, 1995, 
Christopher Hennings etal., 1995b). 
The distribution of PRRSV RNA in tissues can be detected by in situ 
hybridization (Haynes etal., 1997, Larochelle & Magar, 1997, Larochelle et al., 
1996, Sur et al., 1996). PRRSV RNA was detected with a digoxigenin-labeled 
probe from ORF7 in infected cells and in formalin-fixed tissue sections, and the in 
situ hybridization technique differentiated Canadian and European isolates 
(Larochelle et al., 1996). In infected pigs, PRRSV RNA was detected mainly in 
macrophages in lung, lymphoid tissues, and kidney and was detected for longer 
periods than the viral antigen in tissues (Sur etal., 1996). In infected pigs, a high 
virulent isolate may replicate better than a less virulent isolate because positive 
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signal was detected from more pigs in experimentally infected pigs and from more 
cells within the same type of tissues (Haynes etai, 1997). Compared with 
immunohistochemistry, in situ hybridization is more sensitive and can detect more 
tissues with positive signal and more positive cells with stronger signal in the same 
tissue (Larochelle & Magar, 1997). 
Control and prevention 
Many efforts to control PRRS have been tried but few have been successful 
because of the existence of subclinical infections, variation among PRRSV isolates 
and persistence of the virus in infected populations. One method to control PRRS 
is to avoid the introduction of virus into herds by quarantine and testing of incoming 
pigs, restriction of visitors, change of boots and clothes, and cleaning trucks used to 
transport hogs (Goyal, 1993). In Infected herds, several methods are being tried to 
eliminate PRRSV. Whole herd depopulation-repopulation has been widely applied 
in swine industry, but the ability of this method to keep herd PRRSV-free depends 
on the status of the incoming replacement stock (Dee & Joo, 1997). New pigs 
should be housed in a separate facility until test results are available and, only if 
negative, mixed with growing population. Test and removal is the second strategy 
to eliminate PRRS, which needs routine serological testing of the herd. However, it 
is very difficult to use this method if modified live virus vaccine is used and no 
reliable test is available to differentiate field isolates from vaccine virus. 
Segregated early weaning is also one way to eliminate PRRS but is limited 
because PRRSV can cause transplacental infection of the fetus (Dee & Joo, 1997). 
Nursery depopulation is another strategy to control PRRS based on the 
observation that circulation of PRRSV between older infected pigs and recently 
weaned and naive pigs occurs at a single stage of production (Dee et al., 1996). 
Thus the removal of nursery pigs will break the circulation. This method is effective 
for farms with 100-300 sows and seroprevalence of 0-5% (Dee & Joo, 1997). 
Another strategy to control PRRS is mass vaccination with commercially available 
PRRS vaccines and unidirectional animal flow (Dee & Philips, 1998). It was 
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demonstrated to be effective in preventing PRRSV infection in repopulated nursery 
pigs. 
There are several PRRS vaccines available, including RespPRRS/Repro™ 
from Boehrlnger Ingelheim/NOBL Laboratories, Prime Pac PRRS from Schering-
Plough Animal Health Corporation, PRRomiSe from Bayer Corporation and 
inactivated autogenous vaccines from Oxford Laboratories. RespPRRS/Repro™ 
was the first modified live virus vaccine available on market and is recommended 
for use in 3-18 weeks old pigs and in non-pregnant females (Lager & Mengeling, 
1997). It is safe and effective in protecting vaccinated pigs from virulent field virus 
challenge and has cross protection against LV (Boehringer Ingelheim/NOBL 
Laboratories). However, because of the high prevalence of PRRS, variation 
among different field isolates and other factors, the use of the vaccine has resulted 
in different opinions on its efficacy. The outbreak of acute PRRS in 1996 and 1997 
in vaccinated herds is an indication of problem with vaccination. The Prime Pac 
PRRS from Sobering Plough Animal Health Corporation is also a modified live 
virus vaccine which was demonstrated to be safe and to reduce significantly the 
severity and duration of disease following challenge, though it did not prevent 
infection of vaccinated pigs with a virulent heterologous challenge virus (Hesse et 
al., 1997). The effects of this vaccine in field conditions need further observation. 
The PRRomiSe is an inactivated PRRS vaccine made by Bayer Corporation, 
Kansas (Christensen etaL, 1998). The inactivated vaccine was tested in gilts in the 
second trimester of pregnancy with two injections 21 days apart. The number of 
viable pigs bom to the vaccinates was significantly greater than those to non-
vaccinates and viremla was reduced in the vaccinates (Christensen etaL, 1998). 
For modified live virus vaccines, the vaccine virus may be shed from vaccinated 
animals and there might be a potential danger of recombination with field Isolates. 
The advantage of Inactivated vaccines is safety, and their application can benefit 
PRRS elimination or control programs because virus isolation will only detect field 
infections. 
The use of modified live virus vaccine In boars resulted In vaccine virus 
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shedding in semen and reduced semen quality but reduced or no shedding of wild-
type PRRSV after challenge (Christopher Hennings et al., 1997). In another study, 
vaccination with modified live virus vaccine in boars resulted in marked reduction 
in viremia and shedding of virus in semen, but vaccination with inactivated vaccine 
did not change the onset, duration or level of viremia and shedding of virus in 
semen (Nielsen etaL, 1997). In sows, vaccination with inactivated virus resulted in 
protection from homologous challenge with 70% of piglets bom alive and healthy 
compared with 10% in unvaccinated sows (Plana Duran et al., 1997). 
To effectively control PRRS, it Is essential to know where PRRSV is active by 
proper diagnosis, to isolate acutely infected animals and by following proper 
management of pig movement. Vaccines need to be improved and vaccination 
strategies need further study. Differential marker vaccines to differentiate 
vaccinated from infected pigs will be a key component in PRRSV elimination 
programs. 
Conclusion 
PRRS continues to cause heavy economic losses to swine industry and has 
not been under control though many efforts have been made and commercial 
vaccines have been extensively used. The characteristics of this virus, its 
infectiousness, persistence within herds, targeting macrophages, and strain 
variation suggest that this disease will not go away in the foreseeable future. 
Additional research is needed on effective control measures, more efficacious 
and/or marker vaccine, virus-cell interaction, persistent infection, cell mediated 
immune response, basic mechanism of the disease, and significance of strain 
variation. 
On the basis of our knowledge, PRRSV transmission occurs mainly through 
direct contact with blood, oropharyngeal fluids, semen, feces, or urine of an 
infected animal. Transmission by aerosolization is possible over short distance. 
Resident macrophages on mucosal surface, such as tracheobronchial or alveolar 
macrophages, are the target for initial PRRSV infection. Then the virus is 
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transported either Intracellularly or free in lymph to regional lymph node, the 
normal pathway for antigen presentation. PRRSV may replicate in lymph node 
macrophages and may escape lymph node to replicate in macrophages 
throughout the body. During virus replication, a specific signal is induced and 
released from macrophages, and apoptosis is caused in bystander cells. The virus 
may persist in macrophage populations. Emigration of infected macrophages or 
free-circulating virus onto mucosal surfaces and contamination of body fluid may 
be responsible for further transmission. 
After infection, the host develops a typical immune response in terms of 
antibody production within a nomnal time frame and progression. A cell-mediated 
immune response is also induced. However, it is not clear which Is effective In 
clearing PRRSV, the humoral or the cell-mediated immune response. In infected 
pigs, antibody and virus circulate concurrently, which indicates that the antibodies 
were ineffective in clearing viremia. The existence of antibody may enhance virus 
infection as macrophages have Fc-receptor. A competent immune response 
develops subsequent to PRRSV infection though there is persistent infection in 
some pigs. The mechanism of persistent infection is not clear. 
Commercial vaccines are available and used in the control of PRRS. 
However, more efficacious vaccine and better vaccination strategies need to be 
developed and their effectiveness against various field strains needs to be 
evaluated, as demonstrated in the outbreak of acute PRRS. Various methods have 
been tried to control PRRS. Nursery depopulation and strict control of breeding 
herds seems to be the most effective measures for the control of PRRS. Further 
studies on control methods are necessary. 
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CELL SURFACE EXPRESSION OF VIRAL PROTEINS OF 
PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME 
VIRUS IN INSECT CELLS AND THEIR ROLE IN PROTECTION 
AGAINST RESPIRATORY DISEASE 
A paper to be submitted to Vaccine 
Yanjin Zhang, Young Lyoo, Patrick G. Halbur and Prem S. Paul 
Abstract 
The ORFs 2 through 7 products of US porcine reproductive and respiratory 
syndrome virus (PRRSV) were expressed in insect cells for evaluation of protection 
in pigs against the respiratory disease. Surface immunofluorescence was 
observed in insect cells Infected with recombinant baculoviruses containing 
PRRSV ORFs 2 to 6, respectively, indicating that these proteins are most likely 
membrane associated. A protective response was observed in young pigs 
immunized with a combination of GP2, GP3 and GP4 or a combination of GPS, M 
and N proteins. Immunization of pigs with the two combination vaccines reduced 
significantly the severity of respiratory disease (P < 0.001), severity of pneumonia 
(P < 0.05) and duration of viremia compared with those of non-vaccinated controls 
after challenge. These results suggest that these recombinant proteins may be 
used as subunit vaccines against PRRSV infection. 
Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) is the 
causative agent of porcine reproductive and respiratory syndrome (PRRS), which is 
characterized by severe reproductive failure in sows and respiratory disease in 
young pigs, and is one of the causative agent of porcine respiratory complex in 
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p i g s  ' P R R S  h a s  c a u s e d  h e a v y  e c o n o m i c  l o s s e s  a n d  c o n t i n u e s  t o  b e  t h e  n u m b e r  
one health challenge in the pork industry since the first cases were reported in 
1987 The virus is a member of the family Arteriviridae which includes equine 
arteritis virus (EAV), lactate dehydrogenase-elevating virus (LDV) and simian 
hemorrhagic fever virus (SHFV) PRRSV has been reported worldwide and 
there are two genotypes of PRRSV representing European and North American 
isolates. Antigenic and pathogenic differences between PRRSV isolates have also 
been reported 
The genome of PRRSV is a positive-sense single strand RNA of 
approximately 15 kb in size and contains eight open reading frames (ORFs). The 
ORFs 2 to 4 for U.S. isolate VR2385 have been predicted to encode 29.5, 28.7 and 
19.5 kDa membrane-associated products, respectively It has not been directly 
demonstrated that the ORFs 2 to 4 of U.S. PRRSV isolates encode structural 
proteins. The ORFs 2, 3 and 4 of a European isolate, designated as Leiystad Virus 
(LV), have been found to encode 29-30 kDa, 45-50 kDa and 31-35 kDa virion-
associated proteins (GP2, GP3 and GP4), respectively The ORF3 of a 
Canadian PRRSV isolate has been found to encode a non-structural protein 
The ORFs 5, 6 and 7 of PRRSV were found to encode a glycosylated envelope 
(GP5) protein, a membrane (M) protein and a nucleocapsid (N) protein, 
respectively However, due to the difficulty in getting pure individual proteins 
from PRRSV particles, it has been difficult to study the function of individual 
proteins. It is not yet known which viral protein(s) induces a protective immune 
response in pigs, though it is reported that GPS and GP5 of European PRRSV are 
involved in protection by immunization of sows with GP3, GP5 and N proteins 
individually or in combination 
The prevalence of PRRSV in swine herds is high. It is estimated that 60-
80% of herds are infected One of the essential components of an disease 
eradication program is to differentiate vaccinated animal from those exposed to 
wild type virus. It is difficult to achieve with the widespread use of modified live 
virus and killed virus vaccines which lack a differential marker. Subunit vaccines 
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can be used as marker vaccines and will be useful in PRRSV control and 
elimination programs. In order to evaluate if recombinant proteins of PRRSV can 
be used as subunit vaccines, we cloned and expressed ORFs 2 to 7 genes of a 
high virulence U.S. PRRSV isolate in a baculovirus expression vector system 
(BEVS). The BEVS is primarily used for its high yield of heterologous proteins and 
for the similarity to mammalian cells in post-translational modifications. 
In this paper we report on the evaluation of recombinant proteins coded by 
ORF 2 through 7 genes of PRRSV Isolate VR2385 in protection against PRRSV 
infection. The recombinant proteins were analyzed for cell surface location, 
expression, antigenicity and glycosylation in insect cells. These recombinant 
proteins were divided into three groups and tested to see if they could induce a 
protective response in pigs as evidenced by a reduction of severity of clinical 
respiratory disease and pneumonia, and/or duration of viremia after challenge. 
Materials and Methods 
Cells and viruses. ATCC CRL11171 cells were used to propagate PRRSV and 
purification of the virus was done as previously described PRRSV isolate 
ATCC VR2385 was used throughout this study. Spodoptera frugiperda clone 9 
(Sf9) and High Five™ (Invitrogen) insect cells were cultured for the propagation of 
baculovirus. The baculovirus strain Autographa California multinuclear 
polyhedrosis virus (AcMNPV) was used as a parent virus for recombinant 
baculovirus construction. 
Construction of AcMNPV recombinant transfer vector. The nucleotide sequence of 
the ORFs 2 to 7 of PRRSV isolate VR2385 were previously described 
Construction of the baculovirus transfer vectors containing the PRRSV ORFs 2 to 7 
genes was completed with strategies similar to those previously described 
Briefly, PRRSV ORFs 2 to 7 genes were PCR amplified from the plasmid containing 
all these genes separately with primers (Table 1) containing BamH I and Pst 1 
restriction sites for cloning ORFs 2 and 3 genes, and BamH I and EcoR I sites for 
cloning ORFs 4 to 7 genes. The amplified fragments were cut with the restriction 
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enzymes and ligated into the vector pFastBACi (GIBCO BRL) for ORFs 2 and 3 
fragments, and the vector PVL1393 (Invitrogen) for the ORFs 4 to 7 fragments. The 
cloned fragments were inserted under the control of polyhedron gene promoter 
and were verified by restriction endonuclease digestion and PGR amplification. 
The recombinant vectors containing the ORFs 2 to 7 genes were isolated 
separately. For ORFs 2 and 3, the recombinant DNA was transfected into 
competent DHIOBAC E. CO//cells (GIBCO BRL) containing Bacmid, the whole 
genome of baculovirus. For ORFs 4 to 7, plasmids containing the recombinant 
DNA were used to transfect insect cells. 
Transfection and selection of recombinant viruses. For ORFs 2 and 3, recombinant 
baculoviruses were generated with the BAC-TO-BAC™ expression system (GIBCO 
BRL). The isolated recombinant Bacmid DNA was transfected into Sf9 insect cells 
and the cell culture medium was collected as recombinant virus stock. For 
recombinant ORFs 4 to 7 virus construction, the recombinant plasmid DNA and the 
linearized AcMNPV DNA (Invitrogen) were co-transfected into Sf9 cells according 
to manufacturer's instructions (Invitrogen). Putative recombinant baculoviruses 
were selected following three rounds of occlusion body-negative plaque 
purification. The inserted genes in the recombinant viruses were verified by 
hybridization and PGR amplification 
Indirect Immunofluorescence Assay (IFA). I FA has been well described 
elsewhere Briefly, monolayers of High Five™ cells were infected with 
recombinant baculoviruses at a multiplicity of infection of 0.1 and incubated for 72 
hours. Pig anti-PRRSV serum was used to detect viral proteins expressed in insect 
cells. Protein expression was detected in the infected, fixed cells by 
immunofluorescence. Cell surface expression was detected on unfixed and 
unpermeabilized cells incubated with pig anti-PRRSV serum for 1 hour at 4 °C, 
stained with fluorescein-labeled goat anti-pig IgG conjugate for 1 hour at 4 °C, and 
then observed under a fluorescence microscope. 
Immunoblotting. Westem-blot analysis was conducted as previously 
described Extracts from insect cells infected with recombinant baculoviruses or 
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wt AcMNPV were used for this analysis. The proteins were separated by SDS-
PAGE and transferred to nitrocellulose membrane by electrophoresis. The 
membrane was incubated with pig anti-PRRSV serum for 1 hour at room 
temperature. Specific reactions were detected with goat anti-pig IgG peroxidase 
conjugate, followed by color development in 4-chloro-1-naphthol substrate. 
Tunicamycin treatment High Five™ cells were infected with recombinant 
baculoviruses or wt AcMNPV and incubated with 5 ng/ml tunicamycin in cell-culture 
medium from 0 to 72 hours post infection. Non-treated insect cells were infected at 
the same time as controls. Cell lysates were harvested for SDS-PAGE and 
immunoblotting 
Antigenicity of the recombinant proteins. Lysates of insect cells infected with 
recombinant viruses were used to immunize rabbits. Two twelve-week old rabbits 
were injected intramuscularly and subcutaneously with the recombinant proteins. 
Blood was collected 10 days after the second booster injection. Antibodies were 
tested by indirect ELISA Purified PRRSV particles were sonicated and used to 
coat 96-weil plates and goat anti-rabbit IgG peroxidase conjugate was used to 
detect anti-PRRSV antibodies in rabbit serum samples. Pre-immune rabbit serum 
samples were used as negative controls. 
Immunization and challenge of pigs. Seventy-three SPF pigs were randomly 
divided into 5 groups with sixteen pigs in each group except for one group with 
nine pigs (Table 2). Vaccines were formulated by mixing infected insect cells with 
an oil adjuvant according to the manufacturer's instructions (Fort Dodge Animal 
Health Inc., Fort Dodge, lA). Three-week old pigs were injected intramuscularly 
with a 2 ml dose of vaccine containing lysates of 5 x 10^ cells. Three injections 
were carried out at intervals of two weeks. The dose of the second and third 
injections was 2 ml of vaccine containing lysates of 2 x 10^ cells. Pigs were 
challenged with 5 ml of PRRSV isolate VR2385 (10" TGIDso/ml) via intra-nasal 
route 10 days after third injection of vaccine, which was 38 days after vaccination 
began. Rectal temperatures, feed intake, and clinical signs, and clinical respiratory 
disease scores were recorded daily as previously described The clinical 
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respiratory disease score was based on a scale of 0-6 with 6 being the most severe 
form of respiratory disease The average score of each group was calculated 
and compared with that of the control groups. 
Necropsies were performed on half of the pigs randomly selected in the first 
four groups and all pigs in the last group (Table 2) 10 days after challenge. The 
Severity of gross lung lesions was scored to estimate the percentage of the lung 
affected as reported previously ® Briefly, a total of 100 points was assigned to 
different parts of lung and a score was given to reflect the amount of pneumonia in 
each lobe. The total points for all lobes was an estimate of the percentage of the 
entire lung with grossly visible pneumonia. The Average gross lung lesion score of 
each group was calculated and compared with that of the control group. 
The other half of the pigs challenged with virus were tested for viremia for a 
period of four weeks. Serum samples were collected every three days and used 
for virus isolation. The CRL11171 cell monolayers were inoculated with the serum 
samples diluted 1 to 10, incubated at 37 °C for three days, and harvested for 
inoculation of new cell monolayers. An IFA was perfonned on the new cell 
monolayers three days later to determine evidence for virus infection. 
Results 
Construction and verification of recombinant viruses. Recombinant baculoviruses 
containing PRRSV ORFs 2 to 7, separately, were constructed. The presence of 
PRRSV genes was confirmed by DNA hybridization with probes from PRRSV ORFs 
2 to 7 genes and PGR amplification with specific primers from these genes (data 
not shown). In this study, vAc-P2 is designated for recombinant virus containing 
ORF 2, vAc-P3 for that with ORF 3, vAc-P4 for that with ORF 4, vAc-P5 for that with 
ORF 5, vAc-M for that with ORF 6, and vAc-N for that with ORF 7, respectively. 
Surface expression in insect cells. IFA was performed to identify recombinant 
protein expression and to localize the site of antigen production in insect cells. 
High Five™ cells were infected with vAc-P2, vAc-P3, vAc-P4, vAc-P5, vAc-M, vAc-N 
or wt AcMNPV and examined for total protein expression by IFA with pig anti-
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PRRSV serum. Unfixed and unpermeabilized Insect cells were stained at 4 °C to 
detect cell surface immunofluorescence by I FA. There was specific fluorescence 
on cell surface of vAc-P2, vAc-P3, vAc-P4, vAc-P5 and vAc-M infected insect cells 
stained at 4 °C without fixation and permeabilization (Fig. 1). Cell surface staining 
was not detected in either vAc-N or wt AcMNPV infected insect cells. There was 
cytoplasmic fluorescence in recombinant baculovirus infected cells, but no specific 
fluorescence was detected in wt AcMNPV infected cells (Fig. 2). The cytoplasmic 
fluorescence was more intense in vAc-P3, vAc-P4 and vAc-N infected insect cells 
than that in vAc-P2, vAc-P5 and vAc-M infected cells. No fluorescence was 
observed in recombinant virus infected insect cells in the absence of pig anti-
PRRSV antibody (data not shown). 
Antigenicity of the recombinant proteins. IFA results showed that the recombinant 
proteins were expressed in insect cells. The antigenicity of recombinant products 
of ORFs 2 to 7 was tested by Immunization of rabbits with lysates of Insect cells 
infected with recombinant baculoviruses. The anti-PRRSV antibodies were 
detected in the rabbit serum samples by ELISA. The average titers of serum 
samples from rabbits immunized with vAc-P2, vAc-P3 and vAc-P4 cell lysate were 
128, 128 and 256, respectively. The average titers of serum samples from rabbits 
immunized with vAc-P5, vAc-P6 and vAc-P7 cell lysate were 256, 512 and 2056, 
respectively. 
Immunoblotting analysis of expressed recombinant proteins. Expression of the 
recombinant proteins in Insect cells was analyzed by immunoblotting (Fig. 5). The 
Immunoblotting analysis of recombinant GP2, GPS and GP4 showed multiple-band 
species (Fig. 5A). The GP2 expressed in insect cells showed 27 and 29 kDa 
bands. The GPS was detected as multiple bands with M^of 22, 25, 27-S1 and S5-
4S kDa. The GP4 was present as multiple bands with Hof 15, 18, 22, 24, 28 and 
30 kDa. The recombinant GPS also gave multiple bands with M^of 16,18, 20, 24, 
and 26 kDa (Fig. 5B). The recombinant proteins M and N had Hof 19 kDa and 15 
kDa, respectively. These specific protein bands were not detected in insect cells 
Infected with wt AcMNPV. These recombinant proteins were analyzed for 
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glycosylation as the multiple protein bands in immunoblotting suggested 
differential glycosylation. Insect cells infected with recombinant baculoviruses or wt 
AcMNPV were treated with tunicamycin to determine if the recombinant proteins 
were N-glycosylated, as tunicamycin inhibits N-linked glycosylation. Analysis of 
the treated samples from vAc-P2, vAc-P3, vAc-P4 and vAc-P5 infected cells 
showed change in mobility of the multiple bands (Fig. 5), indicating that these 
proteins were glycosylated. After the treatment, the 29 kDa band of the GP2 protein 
disappeared and a 25 kDa band appeared. For the recombinant GPS protein, the 
species of 27-43 kDa disappeared but the 22-27 kDa bands remained unchanged. 
The recombinant GP4 protein was observed as 15 and 18 kDa species after the 
treatment and the 22-30 kDa bands disappeared. For the recombinant GP5 
protein, 16 and 18 kDa bands were unchanged and the 20-26 kDa bands 
disappeared after the drug treatment (Fig. 5B). In contrast, no changes in the 
mobility of M and N proteins were detected after the tunicamycin treatment (Fig. 
5B). 
Immunization and challenge. The recombinant proteins were evaluated for 
protection against PRRSV by immunization of three-week old pigs followed by 
challenge with virulent virus after the third injection. The average clinical 
respiratory disease scores and gross lung lesion (GLL) scores of each group are 
presented in Table 2. Groups 2 and 3 showed significant lower average clinical 
respiratory disease scores (P < 0.001) and GLL scores (P < 0.05) in comparison 
with those of non-vaccinated challenge control group. Compared with the clinical 
scores of non-vaccinated challenge control group, the average clinical scores were 
reduced by 62% and 75% for pigs immunized with vaccines as combination of 
GP2, GP3 and GP4 and as combination of GPS, M and N proteins, respectively. In 
comparison with non-vaccinated challenge control group, groups 2 and 3 had 
reductions in gross lung lesion scores by 35% and 41%, respectively. For group 4, 
the gross lung lesion score was similar to that of non-vaccinated challenged control 
group though clinical score of group 4 was reduced by 36%. The mock vaccinated 
control group had similar scores with the non-vaccinated challenge control group. 
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Our results suggest that the combination of GP2, GPS and GP4 and the 
combination of GPS, M and N proteins can provide partial protection against 
PRRSV associated respiratory disease. 
Viremia test results support the above observations of partial protection by 
recombinant proteins (Table 3). The number of pigs that were viremic in group 2 
and group 3 were 17% and 33%, respectively, of those viremic in non-vaccinated 
challenge control group at day-13 post-challenge. But the number of pigs that 
were viremic in group 4 were similar to those viremic in control group, 83% of the 
control group, indicating that vaccine with a combination of GPS and M proteins 
had no protective effect. None of the pigs were viremic by day-20 post-challenge. 
Discussion 
In this study, we successfully expressed PRRSV ORFs 2 to 7 products using 
a baculovirus expression system. The expressed proteins appeared to be 
authentic as they reacted specifically with PRRSV antibodies in 
immunofluorescence assay and westem-blot analysis, and induced antibodies to 
PRRSV in rabbits. Cells infected with the different recombinant baculoviruses 
showed specific immunofluorescence in IFA. 
Our data suggest that polypeptides encoded by ORFs 2 to 6 are membrane 
associated. This conclusion is based on observation that proteins were expressed 
on the cell surface of unfixed and unpermeabilized insect cells infected with the 
recombinant baculoviruses containing these genes. These results confinned the 
predictions made from deduced amino acid sequence analysis The 
association of these proteins with membrane may be important in PRRS virus 
replication and virus assembly. In contrast to the products of ORFs 2 to 6, the ORF 
7 product, N protein, is located in the cytosol only. This result is consistent with its 
property as a hydrophilic nucleocapsid protein predicted from deduced amino acid 
sequence analysis 
Immunoblotting analysis confirmed that ORFs 2 to 7 were expressed in 
insect cells and glycosylation analysis results show that the recombinant GP2, 
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GPS, GP4 and GPS proteins are glycosylated. The presence of nnultiple protein 
bands for GPS, GP4 and GPS in western-blot is possibly due to differential 
glycosylatlon as tunicamycin treatment eliminated several bands of GPS, GP4 and 
GPS proteins. The 25 kDa band of the recombinant GP2 is likely the core protein 
without a signal peptide and the 27 kDa band is probably due to other types of 
modifications such as O-linked glycosylation or phosphorylation. This result is 
consistent with the report of the European Leiystad virus ORF 2 product The 27 
kDa species of recombinant GPS protein is probably the core protein as it is most 
abundant after tunicamycin treatment. The bands lower than 27 kDa of 
recombinant GPS may be truncated proteins or products of proteolysis. The core 
protein of GP4 is a 15 kDa species and the 18 kDa band after tunicamycin 
treatment is probably due to other modifications. The recombinant LV GP4 protein 
expressed in insect cells was detected as 20-29 kDa bands with a 17 kDa core 
protein The reason for the difference in Mr may be due to the different genotypes 
used. The non-glycosylated leader-free core protein of the recombinant GPS is 
probably 16 kDa. The 26 kDa band possibly represents the fully glycosylated form 
of GPS as described in previous reports The recombinant M and N proteins 
did not undergo N-linked glycosylation in our study, a finding consistent with the 
previous reports 
Our results indicate that these recombinant proteins can induce partial 
protection against PRRSV challenge. Immunization with vaccines comprised of a 
combination of GP2, GPS and GP4 or of a combination of GPS, M and N proteins 
reduced the severity of clinical respiratory disease (P < 0.001) and the severity of 
pneumonia significantly (P < O.OS). Also, fewer pigs in these two groups were 
viremic. However, a combination of GPS and M did not provide any protection as 
there were similar levels of pneumonia and viremia duration in this group as in the 
control group. It was reported that GPS and GPS are capable of inducing some 
protection and that N protein is the most immunogenic in sows but did not 
protection in a sow immunization test with GPS, GPS and N recombinant proteins 
individually or in combination Our results indicate that N protein could be 
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important in inducing protection thougli it is a nucleocapsid protein. The possible 
mechanism could be its potential ability to induce cellular immunity. GPS is an 
envelope protein which commonly induces protective immunity. The combination 
of GP2, GPS and GP4 can induce some protection. This result indicates that these 
three proteins could also be important players in virus infection and host protective 
immune response. 
We have described successful production of six PRRSV proteins in insect 
cells and have tested their efficacy as vaccines. The expression of recombinant 
proteins in insect cells should allow for the purification of large quantities of the 
PRRSV proteins for subsequent biochemical and immunological studies. These 
expressed proteins may be an Important altemative for production of subunit 
vaccines and diagnostic reagents. 
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Table 1. Primers used to amplify PRRSV ORFs 2 through 7 genes with PGR 
ORF Forward primer Reverse primer 
2 5'GCACGGATCCGAATTAACATG 5'GGACGTGGAGATTCACGGTGA 
AAATGGGGT3' GTTGGAAAG 3' 
3 5'CGTGGGATCCTCGTACAATGG 5'GGGGGTGGAGTGTGCCTATGG 
GTAATAGCT 3' AGGTGCGGC3' 
4 S'GTATGGATGGGGAATTGGTTT 5'ATAGGAATTGAAGAAGAGGGG 
GAGGTATAA 3' AGGATAGAG 3' 
5 STGGGAGGATGGGTGTTTAAAT 5'GGTGGAATTGATAGAAAAGGG 
ATGTTGGGG 3' GAAGAGGAG 3' 
6 5'GGGGATGGAGAGTTTGAGGGG 5'GGGAATTGTGGGAGAGGTGAT 
3' TGAG 3' 
7 5'GGGGATGGTTGTTAAATATGC 
G 3' 
S'GGGAATTGAGGAGGGATTG 3' 
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Table 2. Protection of pigs from PRRSV-associated respiratory disease by 
recombinant proteins® 
Group Vaccine Number 
of pigs 
Average 
clinical 
scores 
% of control 
compared 
with NVCC 
Average 
GLL-^ 
scores 
% of control 
compared 
with NVCC 
1 NVCC 16 0.8 100 45.0 100 
2 GP2+GP3 16 0.3 38 29.3 65 
+GP4 
3 GP5+M+N 16 0.2 25 26.5 59 
4 GP5+M 16 0.4 50 41.5 92 
5 Control'' 9 0.6 75 41.1 91 
a. Protection was evaluated by reduction in severity of clinical respiratory disease 
and lung lesions following challenge with virulent PRRSV isolate VR2385. Pigs 
were immunized three times with recombinant proteins prior to challenge. 
b. NVCC - Not vaccinated challenge control. 
c. GLL — Gross lung lesion. GLL scores were averages of 8 pigs for groups 1 to 4 
and 9 pigs in group 5. 
d. Control group pigs were injected with mock vaccine containing wild type 
baculovirus infected cells. 
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Table 3. Evaluation for viremla in pigs immunized with recombinant proteins 
following challenge with virulent PRRSV® 
Viremia at different times after challenge 
Group Vaccine Day-10 %of  Day-13 %of  Day-17 %of  Day-20 
control control control 
1 NVCC 14/16" 100 
a 0
0 to 100 1/8" 100 
n 0
0 
2 GP2+ 10/16 71 1/8 17 0/8 0 0/8 
GP3+GP4 
3 GP5+ M+N 13/16 93 2/8 33 0/8 0 0/8 
4 GP5+M 14/16 100 5/8 83 1/8 100 0/8 
a. Blood samples were collected from all pigs and half of the pigs were euthanized 
at day 10 for groups 1 to 4. The remaining half were screened for viremia at days 
13, 17 and 20. 
b. Number of viremic pigs / Total number of pigs tested. 
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Fig. 1. Cell surface expression of recombinant GP2 (A), GPS (B) and GP4 (C), GPS 
(D) and M (E) proteins in High Five™ cells. The insect cells were inoculated with 
recombinant baculovirus vAc-P2 containing PRRSV ORF 2 (A), vAc-P3 containing 
ORF 3 (B), vAc-P4 containing ORF 4 (C), vAc-P5 containing PRRSV ORF 5 (D), 
vAc-M containing the M gene (E) or vAc-N containing the N gene (F), incubated for 
72 hours, and stained at 4 °C without fixation. Pig anti-PRRSV serum was used to 
react with cell surface recombinant proteins and fluorescein-labeled goat anti-pig 
IgG conjugate was utilized to detect any specific reactions. Note surface 
immunofluorescence present in A trough E but not in F. 
Fig. 2. Detection of recombinant GP2, GPS, GP4, GPS, M and N proteins 
expressed in insect cells by immunofluorescence. The High Five™ cells were 
infected with recombinant baculovirus vAc-P2 containing ORF 2 (A), vAc-PS 
containing ORF S (B), vAc-P4 containing ORF 4 (C), vAc-P5 containing PRRSV 
ORF5 (D), vAc-M containing the M gene (E), vAc-N containing the N gene (F) or wt 
AcMNPV (G), fixed with methanol and reacted with pig anti-PRRSV serum. 
Specific reactions were detected by fluorescein-labeled goat anti-pig IgG 
conjugate and observed under fluorescence microscope. Immunofluorescence 
was detected in A through F, but not in G. 
Fig. 3. Analysis of the recombinant proteins expressed in insect cells by 
immunoblotting. (A). Immunoblotting analysis of recombinant GP2, GPS and GP4 
proteins. MW standards (kDa) are indicated on the left side. 
indicates the absence of tunicamycin in cell culture medium; +, indicates the 
presence of tunicamycin in cell culture medium. (B). Immunoblotting analysis of 
recombinant GPS, M and N proteins. MW standards (kDa) are indicated on the left 
side. indicate the absence of tunicamycin in cell culture medium; +, indicate the 
presence of tunicamycin in cell culture medium. 
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DEPENDENT EPITOPES ON PORCINE REPRODUCTIVE AND 
RESPIRATORY SYNDROME VIRUS 
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Summary 
Monoclonal antibodies (MAbs) against porcine reproductive and respiratory 
syndrome viais (PRRSV) were prepared and characterized. Four MAbs were 
developed from the mice immunized with the recombinant GP4 protein expressed 
in insect cells, and six MAbs were derived from the immunization with recombinant 
GP5 protein. All of the MAbs showed strong perinuclear fluorescence in PRRSV 
VR2385 infected cells by immunofluorescence staining. Among the MAbs to GP5 
protein, one showed strong reactivity in ELISA and recognized a 26 kDa band of 
PRRSV in a western blot assay, while another showed neutralizing activity against 
the VR2385 isolate. Out of the four MAbs to GP4 protein, one showed mild 
reactivity in ELISA with detergent extracted antigen, but had no reactivity in a 
westem-blot assay. The failure of MAb binding to detergent extracted antigen in 
ELISA or in westem-blot analysis indicated that the MAbs were against 
conformatlonally dependent epitopes. Reactivity patterns of the MAbs with PRRSV 
field isolates tested by fixed-cell ELISA showed that there are antigenic variations 
in PRRSV GP4 and GP5 proteins. Development of these MAbs will benefit further 
studies on PRRSV structural proteins as well as in understanding their roles in 
PRRSV pathogenesis. 
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Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) is the 
causative agent of PRRS (Benfield et ai., 1992, Christiansen et al., 1992 & Goyal, 
1993) and is classified in the family Arteriviridae, which also includes equine 
arteritis virus (EAV), lactate dehydrogenase-elevating virus (LDV) and simian 
hemorrhagic fever virus (SHFV) (Gonzelmann et al., 1993 & Meulenberg et al., 
1993). PRRSV Is associated with severe reproductive failure in sows, respiratory 
disease in young pigs, and an influenza-like syndrome in grower-finisher pigs (Hill, 
1990), and has caused heavy economic losses to the swine industry. 
It has been recognized that PRRSV 0RF5 encodes a major glycosylated 
envelope (GPS) protein (Meulenberg et al., 1995 & Mardassi et al., 199S), which is 
speculated to induce neutralizing antibody in the host as does its counterpart in 
LDV and EAV (Plagemann & Moennig, 1992 & Balasuriya et al., 199S). The 
PRRSV 0RF4 was predicted to encode a membrane-associated glycoprotein 
(Morozov et al., 1995). It has not been documented if GP4 of U.S. PRRSV isolate is 
virion-associated and induces neutralizing antibodies though ORF4 of the 
European Leiystad isolate encodes a structural protein and the MAbs to GP4 
showed virus neutralizing activity (VAN Nieuwstadt et al., 1996 & Meulenberg et al., 
1996). It has been established that European PRRSV and U.S. PRRSV strains 
represent two genotypes, and that there are phenotypic, pathogenic and antigenic 
variations among PRRSV isolates (Drew et al., 1995; Mardassi et al., 1994; Meng 
et al., 1995a, b & 1996a: Nelson et al., 1993). Marked differences in virulence 
between U.S. and European PRRSV isolates as well as among U.S. Isolates In 
experimentally infected pigs have also been detected (Halbur et al., 1995 & 1996). 
In order to facilitate further characterization of PRRSV structural proteins, we 
developed monoclonal antibodies against a high virulence PRRSV isolate VR2385 
using recombinant GP4 and GP5 proteins as immunogens. In this paper we report 
the preparation and characterization of these MAbs to PRRSV, and reactivities with 
PRRSV field isolates. 
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Materials and Methods 
Cells and Viruses. The cell line ATCC CRL11171 was used for the propagation of 
PRRSV isolates. Maintenance of the cell line and isolation of the virus were done 
as described previously (Meng et al., 1994 & 1996b). Plasmacytoma cell line 
SP2/0 was used for cell fusion in MAb preparation. A high virulence PRRSV 
isolate ATCC VR2385 was used in antigen preparation for the screening of 
hybridomas secreting PRRSV specific monoclonal antibodies. 
Indirect Immunofluorescence Assay (IFA). Monolayers of ATCC CRL11171 cells 
were inoculated with PRRSV VR2385 at 0.1 multiplicity of infection, incubated for 
48 hrs and fixed with methanol. Hybridoma supematant was added to the fixed-
cell monolayer at 37 "C for 30 min. Fluorescein-labeled goat anti-mouse IgG (H+L) 
conjugate was used to detect the specific reaction. One MAb specific for PRRSV 
nucleocapsid protein (N), PP7eF11, was used as a positive control. Cell culture 
supematant from a non-PRRSV specific MAb, PPAcS, was used as a negative 
control. 
l\/!Ab preparation. The whole insect cell lysates containing recombinant GP4 and 
GPS proteins were used as immunogens to immunize mice. Construction of the 
recombinant baculoviruses containing the PRRSV ORFs 4 and 5 was done with 
strategies similar to those described previously (Bream et al., 1993). Briefly, 
PRRSV ORFs 4 and 5 genes were amplified by polymerase chain reaction (PCR) 
from the template of the pPSP.PRRSV2-7 plasmid (Morozov et al., 1995) with 
primers containing restriction sites for BamH I and EcoR I. The amplified fragments 
were cut with the restriction enzymes BamH 1 and EcoR I, and ligated into the vector 
PVL1393 (Invitrogen) under the control of the polyhedrin gene promoter (O'Reilly et 
al., 1992). The presence of genes was verified by restriction enzyme digestion and 
PCR amplification. Recombinant vector DNA and linearized Autographa California 
multinuclear polyhedrosis virus DNA (Invitrogen) were then co-transfected into Sf9 
cells as per manufacturer's instructions. The inserted genes in the recombinant 
baculoviruses were verified by hybridization and PCR amplification (O'Reilly et al., 
1992). The insect cells were inoculated with the recombinant viruses and then 
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harvested for Immunizatron of mice. The immunization was carried out with 3 to 5 
intraperitoneal injections at two-week Intervals. Splenocytes were fused with 
SP2/0 myeloma cells as previously described (Brown & Ling, 1988). Hybridomas 
were screened for secreting PRRSV specific antibodies with IFA on cells Infected 
with the PRRSV VR2385 Isolate. Positive hybridomas were selected and cloned 
three times. MAbs were Isotyped by ELISA using a commercial kit (Zymed 
Laboratories Inc.). 
Enzyme-linked immunosorbent assay (ELISA). ELISA was performed as 
described previously (Harlow & Lane, 1988 & Ausubel et al., 1992). Briefly, coating 
antigens were extracted with 1% Triton X-100 from cells infected with PRRSV 
Isolate VR2385. MAbs were then tested for specific binding activity with the coating 
antigens on ELISA plates. Lysate from uninfected cells was included as a negative 
antigen control and hybridoma culture fluid from the non-PRRSV specific MAb, 
PPAc8 was Included as a negative antibody control. The PRRSV N-specifIc MAb, 
PP7eF11 was used as a positive control. Specific reactions were detected with 
peroxidase conjugated goat anti-mouse IgG (H+L) followed by addition of substrate 
2,2'-azino-bls (3-ethylbenzthla2ollne-6-sulfonlc acid) (ABTS). Results were 
expressed as the optical density at 405 nm (A405). 
To test the reactivity of the MAbs with PRRSV field isolates, fixed-cell ELISA 
was conducted as previously reported for transmissible gastroenteritis virus 
(SImkins et al., 1989). Briefly, monolayers of ATCC CRL11171 cells were 
inoculated with PRRSV field Isolates at 0.001 multiplicity of infection, incubated for 
48 hrs and fixed with methanol. The free sites were blocked with 1% BSA for 1 
hour at room temperature. Hybridoma culture fluids of MAbs were diluted in two­
fold series and added to the wells In plates. The MAbs PP7eF11 and PPAc8 were 
used as positive and negative controls, respectively. Specific reactions were 
detected as described above. 
Immunoblotting. Western Immunoblot analysis was carried out as described 
previously (Hariow & Lane, 1988). Protein samples were treated under different 
conditions before gel electrophoresis. For denaturing conditions samples were 
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treated at 100 °C for 3 minutes In Laemmll sample buffer containing 2% SDS and 
5% 2-mercaptoethanol and separated by SDS-PAGE. Under non-denaturing 
conditions, samples were treated at 4°C for 20 min in sample buffer containing 1% 
triton X-100 and separated by PAGE. The separated proteins were transferred to a 
nitrocellulose membrane by electrophoresis. The free sites on the membrane were 
then blocked with 3% BSA. MAbs were screened for reactivity with the antigens on 
the membrane using multiscreening apparatus (Bio-Rad Laboratories). Pig anti-
PRRSV serum was used as a positive control and hybridoma culture fluid from MAb 
PPAcS was used as a negative control. Bound MAbs were detected by incubation 
with goat anti-mouse IgG + IgA + IgM peroxidase conjugate and bound polyclonal 
antibodies were detected by goat anti-pig IgG peroxidase conjugate, followed by 
color development in 4-chloro-1 -naphthol substrate. 
Virus neutralization (VN) test Virus neutralizing activity of MAbs was tested as 
described previously (Mecham et al, 1990 & White et al, 1990) with some 
modifications. Hybridoma culture fluid was mixed with the same volume of PRRSV 
dilution containing 30-70 plaque fomriing units, which was diluted with DMEM 
containing 10% guinea pig complement. The virus-antibody mixture was 
incubated at 37 °C for 1 hr, then transferred to six-well plates with ATCC CRL11171 
monolayer cells and incubated at 37 °C for 1 hr. An agarose-medium mixture was 
used to overlay the monolayer. After 3-day incubation at 37 °C, the monolayer was 
stained with 0.05% neutral red in agarose. Pig anti-PRRSV serum was used as a 
positive control and hybridoma cell culture medium from a non-PRRSV specific 
MAb was included as a negative control. 
Results 
PRRSV specific MAbs identified by IFA. Hybridoma supematants were screened 
by IFA on cells infected with PRRSV isolate VR2385. Ten hybridomas detected to 
be positive by IFA were cloned as described in the method section. Six of the 
MAbs were from mice immunized with the recombinant GP5 protein and four were 
from mice immunized with the GP4 protein. All of them showed strong perinuclear 
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fluorescence in VR2385 infected cells, which was different from the cytoplasmic 
staining obsen/ed with PRRSV N protein-specific MAb (Fig. 1). The intensity of 
perinuclear fluorescence was different among the MAbs. No immunofluorescence 
was detected in the negative controls. All ten MAbs were characterized to be an 
IgM isotype. 
Reactivity with PRRSV antigen using ELISA. In order to detennine the sensitivity of 
the epitopes to detergent treatment, we tested the reactivity of the MAbs using 
ELISA, with PRRSV antigen extracted with 1% Triton X-100. Among the MAbs from 
mice Immunized with the recombinant GPS protein, only PP5bH4 showed strong 
reactivity to the PRRSV antigen (Fig. 2). No clear reactivity was detected by ELISA 
between the remaining MAbs and the PRRSV antigen. Among the MAbs from mice 
immunized with the recombinant GP4 protein, only PP4bB3 showed a mild 
reactivity with the PRRSV antigen and the remaining three MAbs failed to react In 
ELISA. Negative controls did not show any reactivity. 
Immunobiotting assay. Westem blot analysis was carried out to determine the 
reactivity of the MAbs with PRRSV antigen, and to detennine if the MAbs were 
against conformationally dependent epitopes. Among the six MAbs prepared from 
mice immunized with the recombinant GPS protein, only MAb PP5bH4 recognized 
a protein of about 26 kDa in purified PRRSV particles separated under denatured 
conditions by SDS-PAGE. This protein corresponded to the Mr of the putative GPS 
protein detected with pig anti-PRRSV serum (Fig. 3). No clear reactivity with 
detergent extracted PRRSV antigen was detected for the remaining five MAbs from 
mice immunized with the recombinant GPS protein in westem blot assay under 
non-denaturing conditions. Of the MAbs from mice immunized with recombinant 
GP4 protein, none showed reactivity with either detergent extracted or denatured 
PRRSV antigen in purified particles or in infected cells in immunobiotting analysis 
(data not shown). No reactivity was detected in negative controls. 
Virus neutralizing activity. Plaque-reduction assay was run to test if these MAbs to 
PRRSV had virus neutralizing activity. Hybridoma culture fluid containing MAb 
PPSdB4, from mice immunized with the recombinant GPS protein had neutralizing 
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activity for PRRSV isolate VR2385. The remaining MAbs failed to show any 
neutralizing activity. Pig anti-PRRSV serum was used as a positive control which 
also had virus neutralizing activity. 
Reactivity with other PRRSV isolates. PRRSV field isolates were propagated to test 
the cross-reactivity of MAbs using fixed-cell ELISA (Table 1). All of the ten MAbs 
reacted with all of the PRRSV isolates tested. However, titers of these MAbs varied 
with different isolates. Reactivity was defined as high if titers of at least 6 MAbs with 
any one isolate were greater than or equal to 256, as medium if the titers were 64 
to 128, and as low if the titers were lower than or equal to 32 (Table 1). Out of the 
23 isolates tested, only PRRSV VR2385 isolate showed high reactivity. Six isolates 
(27%) had low reactivity, 12 isolates (52%) had medium reactivity and the 
remaining 4 isolates had reactivity between low and medium. Two of the MAbs, 
PP4dG6 and PP5bH4 showed lower reactivity with most of the isolates than did 
other MAbs. The MAb PP4bB3 showed the highest reactivity with most of the 
PRRSV isolates tested. 
Discussion 
We have successfully prepared MAbs to GP4 and GPS proteins of PRRSV. 
These MAbs appear specific as they reacted by immunofluorescence, ELISA and 
westem-blot analysis with PRRSV antigen from PRRSV-infected cells but not with 
antigen from uninfected cells. These results also indicated that GP4 and GPS 
proteins are membrane-associated glycoproteins. Perinuclear staining was 
observed with the MAbs against PRRSV GP4 and GPS proteins which suggests 
that GP4 and GPS proteins are probably synthesized and accumulated in the 
endoplasmic reticulum and the Golgi complex in PRRSV-infected cells. This further 
suggests that these proteins are glycoproteins, as post-translational modification 
such as glycosylation takes place in these subcellular compartments (Pfeffer et al., 
1987). These results are consistent with the previous reports that PRRSV GPS 
(Meulenberg et al. 1995 & Mardassi et al., 1995) and GP4 proteins (VAN Nieuwstadt 
et al., 1996) are glycosylated. In contrast, the PRRSV N protein is highly basic and 
62 
hydrophllic, and is synthesized In the cytoplasm of PRRSV-infected cells (Mardassi 
et al., 1996). The difference in intensity of fluorescence staining by different MAbs 
nnay be due to the different epitopes recognized by the MAbs or the different 
binding affinity of the MAbs to the same epitope. 
All of the MAbs characterized were of isotype IgM. This finding was 
surprising as mice were given at least three inoculations before fusion. Two 
possible explanations are that the expressed proteins Inhibited the switch from IgM 
to IgG isotype or that our MAb screening assay favored selection of hybridomas 
secreting IgM isotype. 
Most of the MAbs tested were directed against the conformationally 
dependent epitopes as determined using ELISA with the detergent extracted 
PRRSV antigen. In ELISA, two out of the 10 MAbs showed reactivity with the 
detergent extracted antigen, which suggested that the epitopes recognized by 
these two MAbs were resistant to detergent treatment. The corresponding epitopes 
of the other 8 MAbs were sensitive to detergent treatment, and were possibly 
conformationally dependent. 
The ELISA results were further confirmed by westem-blot analysis. The 
epitopes recognized by nine MAbs were sensitive to detergent treatment and were 
conformationally dependent. One MAb reacted with a 26 kDa PRRSV protein, 
which corresponds to the GPS protein in size (Meulenberg et al. 1995 & Mardassi 
et al., 1995) and verifies that this MAb is against GPS protein. The MAb PP4bB3 
showed reactivity with PRRSV antigen in ELISA but not in westem-blot analysis, 
which could be due to epitope loss or alteration during electrophoresis and 
transfer. 
One MAb, PP5dB4, obtained from mice immunized with the recombinant 
GPS protein had virus neutralizing activity for PRRSV isolate VR238S. This virus 
neutralizing MAb provided evidence that at least part of the epitope on GPS protein 
is located on the virion surface and is accessible to the MAb. The neutralizing 
epitope appears to be conformationally dependent as this MAb did not show any 
reactivity with the detergent extracted PRRSV antigen using ELISA or westem-blot 
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analysis. 
Antigenic diversity has been shown among PRRSV field isolates using 
monoclonal antibodies to PRRSV and nucleic acid analysis (Nelson et al., 1993; 
Drew et al., 1995; Kapur et al., 1996 & Wieczorek-Krohmer et al., 1996). Draw et 
al. (1995), and Pirzadeh et al. (1997) did not find common recognition sites, but 
Nelson et al. (1993), Wieczorek-Krohmer et al. (1996), Dea et al. (1996) and 
Rodriguez et al. (1997) reported common antigenic sites between the two 
genotypes. We found that most of the MAbs described in this report did not react 
with European prototype PRRSV strain LV by immunofluorescence assay and that 
two of the MAbs (PP4cB11 and PP5eA12) had a very weak reaction with LV (data 
not shown), hence they were not examined further by fixed-cell ELISA. We have 
shown that there Is antigenic diversity among PRRSV field isolates detected by 
MAbs to GP4 and GP5 proteins. This was detected by fixed-cell ELISA as most of 
these MAbs recognized conformationally dependent epitopes and these epitopes 
appeared to have been preserved in fixed cells. The difference in reactivity of 
MAbs with PRRSV isolates was consistent with the variations observed in the 
amino acid sequences of ORFs 4 and 5 of VR2385, ISU22, ISU55 and RP45 
isolates predicted from nucleotide sequences (Meng et al., 1995a ) and of other 
isolates studied in nucleotide sequences (Kapur et al., 1996). 
In this report we described for the first time about MAbs against GP4 protein 
of North American PRRSV. Along with other MAbs reported before, these MAbs 
will be helpful in the typing of PRRSV isolates and epitope mapping about GP4 and 
GPS proteins. The MAbs described here should also be helpful for further 
characterization of PRRSV structural proteins and PRRSV pathogenesis. 
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Fig. 1. Immunofluorescence assay (IFA) of the MAbs on PRRSV-infected ATCC 
CRL11171 cells. Hybridoma culture fluid was tested by IFA and perinuclear 
immunofluorescence was observed with MAb PP4bB3 directed against the 
recombinant GP4 protein (A) and MAb PP5dB4 directed against the recombinant 
GPS protein (B). In contrast, cytoplasmic immunofluorescence was detected with 
MAb PP7eF11 directed against N protein (C). No immunofluorescence was 
detected with control MAb PPAcB (D). 
Fig, 2. Reactivity of the MAbs with detergent extracted PRRSV antigen in ELISA. 
Plates were coated with the antigen extracted from PRRSV-infected cells with 1% 
Triton X-100 detergent and blocked with 1% BSA. Hybridoma culture fluid was 
tested along with positive and negative controls, PP7eF11 and PPAcS, 
respectively. Specific reactions were detected with anti-mouse IgG peroxidase 
conjugate. ABTS substrate was incubated in the plates for 20 min before 
absorbance A405 was measured. The first four MAbs starting from PP4bB3 are from 
mice immunized with the recombinant GP4 protein, and the next six MAbs starting 
from PP5bH4 are derived from immunization with the recombinant GPS protein. 
Fig. 3. Reactivity of the GPS specific MAbs with PRRSV in immunoblotting. MW 
standards (in kDa) are indicated on the left side of the figure. Lanes: 1, PPSdB4; 2, 
PP5bH4; 3, Negative control: PPAcB; 4, Positive control: pig anti-PRRSV serum; 5, 
Negative control: normal pig serum. 
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Table 1. Reactivity® of the MAbs with PRRSV field isolates detected with fixed-cell ELISA 
Virus Isolate MAbs to GP4 protein MAbs to GPS protein MAb to N 
Name Source PP4bB3 PP4bC5 PP4CB11 PP4CIG6 PP5eA12 PP5eD3 PP5dB4 PP5cH5 PP5CG12 PP5bH4 PP7eF11 
VR2385 Iowa 512 64 512 32 >256 >256 >256 512 256 64 >1600 
ISU-4 Iowa 1024 128 32 <32 32 <32 <32 128 64 <32 >3200 
iSU-22 Iowa 512 64 32 32 128 128 64 128 32 32 >3200 
iSU-28 Iowa 1024 64 128 <32 256 256 128 128 64 32 >3200 
ISU-33 Iowa 128 32 32 <32 64 128 64 128 16 <32 >3200 
ISU-51 Iowa <8 <8 <8 32 256 256 64 <8 8 <32 800 
ISU-55 Iowa 512 16 16 <32 128 128 64 128 64 32 >3200 
iSU-79 Iowa 512 64 32 <32 64 64 64 128 32 32 >3200 
RP10 Iowa 128 32 16 128 >256 >256 128 64 64 32 >3200 
RP11 Iowa 1024 8 32 >256 >256 >256 128 128 32 <32 >1600 
RP12 Iowa 1024 64 1024 64 <32 128 <32 256 64 <32 >1600 
RP15 Minnesota 512 512 512 <32 <32 <32 <32 128 128 <32 >1600 
RP17 Virginia 64 32 16 64 128 128 32 64 32 <32 >3200 
RP18 Virginia 1024 16 64 <32 <32 <32 32 64 64 32 >1600 
RP20 Virginia 512 256 1024 32 64 128 64 512 256 <32 >1600 
RP22 Iowa 512 32 32 <32 64 64 32 128 64 <32 >3200 
RP24 Iowa 1024 128 32 <32 <32 32 32 128 64 32 >3200 
RP29 Iowa 1024 512 64 32 128 128 32 128 64 <32 >3200 
RP31 Iowa 32 <32 <32 32 32 32 64 128 64 32 >3200 
a. Reactivity was expressed as titers of the reaction of MAbs with the PRRSV isolates. End-point titers were 
expressed as the reciprocal of the highest dilution of the MAbs showing absorbance A405 larger than the sum of 
average negative control's A405 plus 3 standard deviations. 
Table 1. (continued) 
Virus Isolate MAbs to QP4 protein MAbs to GPS protein MAbtoN 
Name Source PP4bB3 PP4bC5 PP4CB11 PP4dG6 PP5eA12 PP5eD3 PP5dB4 PPScHS PP5CG12 PP5bH4 PP7eF11 
RP36 Iowa 32 <32 <32 32 <32 64 32 32 32 32 >3200 
RP40 Missouri 128 32 32 64 64 128 64 128 32 32 >3200 
RP45 Minnesota 128 32 256 128 128 >256 >256 256 64 32 >1600 
RP46 Minnesota 256 64 32 32 32 128 32 128 64 32 >3200 
73 
CHARACTERIZATION OF PORCINE REPRODUCTIVE AND 
RESPIRATORY SYNDROME VIRUS RECEPTOR MOIETIES ON 
CELL SURFACE OF A SUSCEPTIBLE CONTINUOUS CELL 
LINE AND DETECTION OF AN 18 KDA VIRAL PROTEIN 
BINDING TO TARGET CELLS 
A paper to be submitted to Archives of Virology 
Yanjin Zhang, Theerapol Sirinarumitr and Prem S. Paul 
Summary 
Binding of porcine reproductive and respiratory syndrome virus (PRRSV) to 
the cells of a susceptible cell line, ATCC CRL11171, was detemriined by a virus 
binding assay. The binding was blocked by purified non-labeled PRRSV particles 
but not by PRRSV ORFs 2 to 6 products expressed in insect cells, suggesting a 
potential requirement of interaction between viral structural proteins in PRRSV 
virion. Enzymatic treatment of the cell monolayers reduced virus binding, an 
evidence for the proteinaceous nature of PRRSV receptor. Noncytolytic treatment 
of cell monolayers with octyl-glucoside reduced virus binding, suggesting that 
PRRSV receptor activity could be extracted from the cell surface. 
Immunoprecipitation of cell surface extract solutions reacted with purified PRRSV 
particles did not yield any specific protein band, which suggests that PRRSV 
receptor moieties exist in low concentration on the cell surface. An 18 kDa PRRSV 
protein was found to bind to the cells by adsorption assay with radiolabeled 
PRRSV-infected cell lysate. Glycosylation did not change the protein binding 
ability to the cells and the protein was not glycosylated. The attached protein was 
immunoprecipitated with monoclonal antibody to the membrane (M) protein of 
PRRSV. 
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Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) is a member 
of tfie family Arteriviridae which includes equine arteritis virus (EAV), lactate 
dehydrogenase-elevating virus (LDV) and simian hemorrhagic fever virus (SHFV) 
[6, 10, 32]. PRRSV is the causative agent of porcine reproductive and respiratory 
syndrome characterized by severe reproductive failure in sows and respiratory 
disease in young pigs [10, 14]. PRRSV has been reported worldwide and there are 
two genotypes of PRRSV representing European and North American isolates [11, 
12, 16, 17, 25, 29, 31, 36]. Antigenic and pathogenic differences between PRRSV 
isolates have also been reported [11, 12, 16, 29, 31]. 
The genome of PRRSV is a positive-sense single strand RNA of 
approximately 15 kb in size and contains eight open reading frames (ORFs). ORFs 
la and lb are believed to encode RNA replicase protein [6]. The ORFs 2 to 4 
encode viral structural glycoproteins GP2, GP3 and GP4, respectively [33, 40]. The 
ORFs 5, 6 and 7 of PRRSV encode glycosylated envelope (GP5) protein, 
membrane (M) protein and nucleocapsid (N) protein, respectively [26, 34]. 
Neutralizing activity has been associated with monoclonal antibodies (MAb) to GP4 
[40] and GP5 [38], suggesting that GP4 and GPS may play important roles in virus 
binding and entry into susceptible cells. But none of these proteins has been 
shown to be associated with receptor binding and tissue tropism. GPS and M 
proteins have been found to form disulfide-linked heterodimers [24], similar to their 
counterparts in EAV and LDV [7, 9]. Disruption of the disulfide bond in LDV 
resulted in abrogation of virus infectlvity, suggesting a major role of their 
association for proper virus-receptor interaction [9]. 
PRRSV can replicate in a few established cell lines in vitro [3, 23, 30]. The 
main mechanism that restricts the virus replication in other cell lines has been 
shown to be the failure of PRRSV binding to cells [20]. Entry of PRRSV in cells has 
been reported to be through a low pH-dependent receptor-mediated endocytic 
pathway [21]. However, nothing is known about the biochemical nature or the 
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cellular function of PRRSV receptor on cells of permissive cell lines. It has recently 
been reported that a 210-kDa membrane protein is a putative PRRSV receptor on 
porcine alveolar macrophages, but it is absent on cells of a PRRSV-permissive cell 
line [8]. 
In this paper we report the studies on PRRSV receptor on CRL11171 cells 
through virus binding assay and detection of an 18 kDa viral protein binding to the 
cells. 
Materials and Methods 
Cells and viruses. ATCC CRL11171 cells were used to propagate PRRSV as 
previously described [11, 28]. PRRSV isolate ATCC VR2385 [28, 35] was used 
throughout this study. For purification of the virus, cell culture medium harvested 
from infected cells were clarified at 8,000 xg for 20 min and concentrated at 
100,000 xg for 3 h. The pellet was resuspended in NET (100 mM NaCI, 10 mM 
Tris-CI, pH7.4, 1 mM EDTA) buffer and the virus suspension was loaded onto a 10-
50% discontinuous accudenz (Accurate Chemical & Scientific Corporation, 
Westbury, NY) gradient. Virus band was collected after 18 h centrifugation at 
200,000 xg. Accudenz was removed from the virus band with dilution In NET buffer 
and concentration of the virus. The purified virus was stored at -80°C until use. 
Radiolabeled virus. PRRSV VR2385 was used to prepare radiolabeled virus as 
described previously [41]. Briefly, ATCC CRL11171 cells were inoculated with 
VR2385 at 0.1 multiplicity of infection (MOI). At 3 h post infection, the cells were 
starved in methionine free DMEM for one hour, following which the medium was 
replaced with DMEM containing 50 fici/ml of ^®S-methionine (Trans ^®S-label; ICN 
Radiochemicals, Inc.). Cell culture medium was harvested 24 h post-infection and 
radiolabeled virus was concentrated and purified by gradient centrifugation. 
Purified virus contained approximately 10® TCIDgo/ml and 2000 cpm/^l. 
Virus binding assay. The virus binding assay was done as previously described [4, 
22]. Briefly, ^®S-labeled purified PRRSV was incubated with CRL11171 cells at 4°C 
for 1 h followed by three washes with cold phosphate-buffered saline (PBS) pH7.2. 
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Cells were then solubllized in 200 jil 2% Nonidet P40 lysis buffer, and the cell-
associated radioactivity was determined by liquid scintillation spectrometry. The 
medium and washing solutions were collected from individual wells and 
radioactivity was also determined. Percentage of binding was calculated by 
dividing the cell-associated radioactivity with total radioactivity. For blocking assay 
of virus binding, lysate containing PRRSV recombinant GP2, GPS, GP4, GPS and M 
proteins expressed in insect cells were used. The expression strategy has been 
described recently [42]. 
Enzyme treatment of cell monolayers. Treatment of cells with enzymes was done 
as reported [5]. Briefly, confluent monolayers of GRL11171 cells grown in 24-well 
plates were washed twice with PBS and incubated In DMEM at the indicated pH for 
15 min. Various enzymes were diluted in DMEM and added to the cell monolayers 
at indicated concentrations. The cells were Incubated under conditions specified in 
Table 1 and then washed with cold PBS. The treated cells were used for virus 
binding assay. Virus bound to cells in treated wells was expressed as percentage 
of virus bound in control monolayers. 
Cell surface extraction. To test the effect of detergent octyl-glucoside (OG) 
treatment on virus binding, cell monolayers were treated with various 
concentrations of OG at room temperature for 30 min, washed with cold PBS and 
used in virus binding assay [5, 27]. Virus binding in treated wells was expressed 
as a percentage of binding in control monolayers. 
Adsorption studies. Radiolabeled lysate from PRRSV-infected CRL11171 cells 
was prepared as previously described [1]. Cell monolayers in 24-well plates were 
used in this study and 50 |xl of radiolabeled lysate per well was added to the 
monolayers. After 1.5 h gentle rocking at 4°C, the cells were washed with cold 
PBS three times and lysed in 30 p.1 of Laemmli sample buffer. The samples were 
analyzed In SDS polyacrylamide gels and fluorography. When the proteins bound 
to the cells were checked by immunoprecipltation, the cells were lysed in 1% 
Nonidet P40 lysis buffer for 30 min at 4°C and then centrifuged for 10 min in a 
microcentrifuge. The supernatant was used for immunoprecipltation. 
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Tunicamycin treatment of infected cells. To inhibit N-iinksd glycosylation, 
tunicamycin was added to PRRSV-infected cells as described previously [37]. 
Tunicamycin was added to the cell culture medium at 5 |ig/ml final concentration. 
Cell lysate was prepared as described previously [1 ] and used for adsorption 
studies. 
Radioimmunopreclpitation (RIP). Immunoprecipitation and gel electrophoresis 
were performed as described previously [15]. Briefly, the clarified lysate from cells 
with bound proteins was incubated with MAbs to PRRSV at 4°C for 3 h. Protein A 
sepharose beads (Sigma Chemical Co., St. Louis, MO) were then added to the 
mixture and incubated at 4°C for 1 h. The complex of antibody-antigen-protein-A 
beads was pelleted by centrifugatlon and washed three times with cold PBS 
containing 1% Nonidet P40. The final pellet was resuspended In Laemmli sample 
buffer, and analyzed by SDS polyacrylamide gel electrophoresis and fluorography. 
Results 
Binding of PRRSV to cells. Radiolabeled PRRS virus bound to CRL11171 cells in 
a saturable way as the binding reached plateau after 2 h incubation at 4°C (Fig. 
1 A). The percentage of virus bound to cells was about 5% when the cell 
monolayers were incubated with 10 MOI virus. The low percentage of virus binding 
was possibly due to limited number of PRRSV receptors since a similar percentage 
of binding was observed when the supernatant of the first time binding was 
transferred to new cells for the second time binding and then transferred to new 
cells again for the third time binding (data not shown). 
Purified non-labeled PRRSV particles blocked the binding of radiolabeled 
counterparts (Fig. 1B). PRRSV recombinant proteins expressed in insect cells 
were used for the blocking assay to determine which viral protein Is involved in 
virus binding. They were either added to cell monolayers one hour earlier or 
simultaneously with radiolabeled PRRSV particles. Recombinant GP2, GP3, GP4, 
GPS, M or a combination of GP4, GPS, and M proteins did not show any blocking 
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activity compared with wild type baculovirus-infected cell lysate (data not shown), 
indicating that interaction between viral proteins in PRRSV virions Is present to 
maintain proper conformation for virus binding. 
Effects of cell surface treatment with enzymes. CRL11171 cell monolayers were 
treated with various enzymes as indicated In table 1, washed and then receptor 
activity was measured with virus binding assay. Treatment with chymotrypsin, 
trypsin, and papain at 10 pg/ml reduced virus binding over 40%, suggesting the 
involvement of a protein species in the virus receptor for the interaction with 
PRRSV particles. Treatment with phospholipase C reduced virus binding over 
50% at 10 units/ml, which indicate the involvement of lipid in the virus receptor 
integrity. 
Extraction of PRRSV receptor activity with OG. Octyl-glucoside was used to test if 
the cell surface receptor can be extracted with non-cytolytic detergent treatment. 
Treating the cells with OG over 0.05% reduced virus binding over 50% (Fig. 2). At 
concentrations over 0.3% of OG, cell lysis became apparent. OG extract solutions 
of radiolabeled cell surface proteins were precipitated with purified PRRSV 
particles to detect virus binding proteins in the extracts, but no specific protein band 
was found after immunoprecipitation (data not shown). 
Binding of an 18 kDa protein to cells. An 18 kDa viral protein from PRRSV-infected 
cell lysate was found to bind to GRL11171 cells at 4°C in an adsorption assay (Fig. 
3). After the cell monolayers with bound proteins were washed three times, the 18 
kDa protein was still bound to the cells but was absent in the cells incubated with 
the radiolabeled normal cell lysate control. To test the effect of glycosylation on the 
binding, we treated PRRSV-infected cells with tunicamycin to inhibit N-linked 
glycosylation in radiolabeled proteins. The radiolabeled lysate was then added to 
react with the cell monolayers. The tunicamycin treatment did not change the 
binding of the 18 kDa protein to the cells or its mobility in gel electrophoresis (Fig. 
4A), implying that this protein was not N-glycosylated and its binding was not 
affected by N-glycosylation. 
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Immunoprecipitation of the attached protein. The clarified lysate from adsorption 
assay was used to react with MAbs to PRRSV. The MAb against PRRSV M protein 
precipitated the 18 kDa protein from the lysate of cells with attached proteins (Fig. 
4B), suggesting the attached protein was M. The MAb against GPS protein failed to 
precipitate the 18 kDa protein. 
Discussion 
The main mechanism that restricts PRRSV replication in non-permissive cell 
lines has been shown to be the failure of virus binding to cells [20]. However, the 
biochemical nature of virus receptor on PRRSV-permissive cell line is not known. 
In this study, we report the interaction of PRRSV and its receptor on CRL11171 
cells, the preliminary characteristics of the PRRSV receptor, and identification of the 
18 kDa viral protein binding to the cells. The PRRSV binding reached plateau after 
2 h incubation at 4°C and was blocked by non-labeled PRRSV particles. The 
binding percentage was low even when 10 MOI of radiolabeled virus were added. 
The low percentage of binding was possibly due to limited number of PRRSV 
receptors on the cell surface, because a similar percentage of binding was 
observed when the supernatant was transferred to other wells for the second and 
third time binding. A similar percentage of binding was observed when the virus 
binding assay was carried out on porcine alveolar macrophages (data not shown). 
This binding profile Is similar to that of LDV binding to mouse macrophages [19]. 
To identify the viral protein involved in virus binding, we carried out virus 
binding blocking assay with PRRSV recombinant proteins. No blocking activity 
was found, which implies that interaction between different proteins might be 
essential in the composition or maintenance of proper conformation of receptor 
binding epitopes on PRRSV virion. 
To treat cells or cell membranes with various enzymes and test the effect of 
such treatment on virus binding is a commonly used method to determine whether 
viral receptor is a protein, lipid, or carbohydrate moiety [2, 18, 39]. The PRRSV 
binding assay on the cells treated with enzymes revealed that the PRRSV receptor 
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contains protein moieties as protease treatment of the cell monolayers reduced the 
virus binding. At high concentrations, phospholipase C reduced PRRSV binding, 
suggesting the involvement of lipid in the PRRSV receptor integrity. 
The nonionic detergent OG has been used to extract the receptors for 
vesicular stomatitis virus, polyoma virus, Semliki Forest virus and simian virus 40 
from intact cell monolayers [5,13, 27, 39]. OG has been used for the noncytolytic 
extraction of surface proteins, and extract solutions have been examined for the 
presence of virus binding proteins [5, 27]. We used OG to examine the PRRSV 
receptor moieties on GRL11171 cell surface. OG extraction reduced PRRSV 
binding to the cell surface. Purified whole PRRSV particles were used to react with 
virus binding proteins in OG extracts, but no specific protein band was found after 
immunoprecipitation, indicating that the PRRSV receptor moieties exist in low 
concentration on CRL11171 cell surface. This result was consistent with the 
observation of low percentage binding in the virus binding assay. 
Our results showed that an 18 kDa protein of PRRSV bound to GRL11171 
cells and was probably the M protein. The 18 kDa protein bound to target cells was 
not detached after three washes demonstrating its specific binding. This binding 
was absent from cells incubated with the radiolabeled normal cell lysate. 
Tunicamycin treatment of PRRSV-infected cells did not affect the 18 kDa protein 
binding, indicating that glycosylation was not necessary for the binding activity. 
However, our study did not exclude the possibility that glycosylation may be 
important in the infectious virion to maintain correct conformation of viral surface 
structures. The disulfide-linked GP5-M heterodimer in PRRSV virions [24] may play 
important roles in this context. 
The immunoprecipitation of the 18 kDa protein from lysate of cells with 
attached proteins by MAb against M protein provides evidence that M protein can 
bind to cells. This finding was surprising as M is a transmembrane protein without 
reported glycosylation [34]. Monoclonal antibodies against GP4 and GPS have 
been associated with neutralizing activity [38, 40], suggesting their involvement in 
virus-cell interaction. However, the identity of PRRSV protein responsible for viral 
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attachment has not been demonstrated. It Is possible that GP4 and GPS proteins 
are involved in the initial contact of the virus to target cells and that the neutralizing 
monoclonal antibody reaction abolishes the initial virus-cell interaction. The M 
protein might be responsible for the secondary binding or membrane fusion. 
In this study we have provided evidence that M protein binds to target cells, 
however, our studies do not unequivocally establish M as the PRRSV viral 
attachment protein. The binding assay employing metabolically labeled viral 
proteins may not accurately reflect events that mediate virus binding of infectious 
virions to cells. They do, however, provide clues to the virus-cell interaction. 
Further studies on PRRSV receptor and viral attachment protein(s) will provide 
more evidence of virus-cell Interactions. 
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Fig. 1. PRRSV binding to CRL11171 cells. (A). PRRSV bound to the cells In a 
saturable way. The virus binding assay was carried out at 4°C for various times on 
monolayers of duplicate wells in 24-well plate and radioactivity associated with 
cells was measured by liquid scintillation spectrometry. Percentage of binding was 
calculated by dividing the cell-associated radioactivity with total radioactivity. 
Values indicated are averages of three cultures. (B). The virus binding was 
blocked by non-labeled PRRSV particles. Various concentrations of PRRSV 
particles were added to the monolayers to test their ability to compete with 
radiolabeled PRRSV. Percentage of binding indicated on Y-axis was the value 
compared with the binding of control, which was defined as 100%. 
Fig. 2. Extraction of PRRSV receptor with octyl-glucoside (OG). Various 
concentrations of OG were added to the cell monolayers to test the effect of OG on 
virus binding. After incubation for 30 min at room temperature, the monolayers 
were washed with PBS and used in virus binding assay. Concentrations of OG 
over 0.3% resulted in cell death. 
Fig. 3. Binding of an 18 kDa viral protein to CRL11171 cells. Lysate from 
radiolabeled PRRSV-infected cells was added to the monolayers and incubated at 
4°G for 1.5 h. Then the monolayers were washed for one, two or three times with 
cold PBS and lysed with Laemmli sample buffer. Lysate from radiolabeled normal 
cells was used as a control. 
Fig. 4. The effect of glycosylation on binding of the 18 kDa protein and 
immunoprecipitation of the protein with MAb. (A). Tunicamycin was used to treat 
the PRRSV-infected cells before and during radiolabeling. The cell lysate from 
tunicamycin treated cells was used for adsorption assay. 
(B). Immunoprecipitation of the attached protein with MAbs to PRRSV. Lysate from 
cells with the attached proteins was used to react with MAbs to PRRSV. Lane 1: 
MAb P246 to GPS protein, lane 2: MAb P6 to M protein. 
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Table 1. Effect of enzymes on PRRSV binding to CRL 11171 cells 
Enzyme Concentration % binding compared 
with control 
None 100 
Phospholipase C® 1 U/ml 102 
5 U/ml 110 
10 U/ml 47 
Trypsin" 10 jig/ml 39 
100 pg/ml 19 
Chymotrypsin" 10 pg/ml 60 
100 pg/ml 28 
Papain" 10 lag/ml 53 
100 ug/ml 9 
® Reaction condition: pH7.3, 37°C for 30 min. 
" Reaction condition: pH7.3, 25°C for 30 min. 
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ANTIGENIC VARIATION IN PORCINE REPRODUCTIVE AND 
RESPIRATORY SYNDROME VIRUS ISOLATES DETERMINED 
WITH MONOCLONALANTIBODIES TO GP2, GPS AND M 
PROTEINS 
A paper to be submitted to Archives of Virology 
Yanjin Zhang and Prem S. Paul 
Summary 
Monoclonal antibodies (MAbs) against porcine reproductive and respiratory 
syndrome virus (PRRSV) were prepared and characterized. The recombinant 
proteins of U.S. PRRSV isolate VR2385 were expressed in insect cells and used to 
immunize mice. MAbs were developed from mice immunized with PRRSV 
recombinant GP2, GPS and M proteins. Ail of the MAbs showed strong perinuclear 
fluorescence in PRRSV VR2385 infected cells by immunofluorescence staining. 
Reactivity pattems of the MAbs with PRRSV field Isolates tested by fixed-cell ELISA 
showed that there were antigenic variations among PRRSV isolates. It was found 
that VR2385 and its progeny after 85 passages in a cell line had different reactivity 
with the MAbs. Antigenic variation analysis with the maximum parsimony algorithm 
indicated that there were at least three groups in thirty-three U.S. PRRSV isolates 
based on an epitope tree diagram. Development of these MAbs will benefit further 
studies on PRRSV structural proteins as well as in understanding their roles in 
PRRSV pathogenesis. 
Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) has been 
known to cause severe reproductive failure In sows and respiratory disease In 
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young pigs and is the causative agent of porcine reproductive and respiratory 
syndrome (PRRS) [1, 5, 8, 11]. PRRSV has been found worldwide and has caused 
heavy economic losses to the swine industry. It continues to be the number one 
health challenge of swine industry. PRRSV is classified in the family Arteriviridae, 
which includes equine arteritis virus (EAV), lactate dehydrogenase-elevating virus 
(LDV) and simian hemorrhagic fever virus (SHFV) [4, 6]. 
The genome of PRRSV is a single positive strand RNA about 15 kb In size 
and has eight open reading frames (ORFs) [19]. PRRSV ORFs 5 through 7 encode 
a major glycosylated envelope protein (GPS), a membrane (M) protein and a 
nucleocapsid (N) protein [14, 19]. ORFs 2 through 4 of the European Leiystad virus 
encode virion associated proteins named GP2, GPS and GP4, respectively [20, 24]. 
The European and U.S. PRRSV strains represent two genotypes, and that there 
are phenotypic, pathogenic and antigenic variations among PRRSV isolates [7, 13, 
16, 18, 22], Marked differences in virulence are found between U.S. and European 
PRRSV isolates as well as among U.S. isolates have also been detected [9, 10]. 
Detailed characterization of viral proteins and their role In virus Infection has been 
difficult due to the shortage of monoclonal antibodies against GP2, GPS and M 
proteins of U.S. PRRSV Isolate. In order to facilitate molecular characterization of 
PRRSV and its pathogenesis, we developed monoclonal antibodies against 
PRRSV isolate VR2385 using recombinant GP2, GPS and M proteins as 
immunogens. We describe here the preparation of MAbs against GP2, GPS and M 
proteins, their reactivities with PRRSV isolates and antigenic variation among these 
isolates. 
Materials and Methods 
Cells and Viruses. The cell line ATCC CRL11171 was used for the propagation of 
PRRSV isolates as described previously [15, 17]. Plasmacytoma cell line SP2/0 
was used for cell fusion in MAb preparation. PRRSV isolate ATCC VR2S85 [15, 17] 
was used to prepare antigen for the screening of hybridomas secreting PRRSV 
specific monoclonal antibodies. 
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Indirect Immunofluorescence Assay (IFA). Monolayers of CRL11171 cells were 
inoculated with PRRSV VR2385 at 0.1 multiplicity of infection, incubated for 48 h 
and fixed with cold methanol. Hybridoma supernatant to be tested was incubated 
on the fixed-cell monolayer at 37 °C for 30 min. Fluorescein-labeled goat anti-
mouse IgG (H+L) conjugate was added to detect the specific reaction. One MAb, 
PP7eF11, specific for PRRSV N protein was used as a positive control and one 
non-PRRSV specific MAb, PPAcS, was used as a negative control. 
MAb preparation. The whole insect cell lysates containing recombinant GP2, GPS 
and M proteins were used to immunize mice. Construction of the recombinant 
baculoviruses containing the PRRSV ORFs 2, 3 and 6 was done with strategies 
similar to those described previously [2]. Briefly, PRRSV ORFs 2, 3 and 6 genes 
were amplified by polymerase chain reaction (PGR) and ligated into transfer vector. 
The resulting recombinant plasmid DNA and linearized wild type baculovirus DNA 
(Invitrogen) were then co-transfected into insect cells as per manufacturer's 
instructions. The insect cells infected with the recombinant viruses were used for 
immunization of mice. The Immunization was carried out with 3 to 5 intraperitoneal 
injections at two-week intervals. Splenocytes were fused with SP2/0 myeloma 
cells as previously described [3]. Hybridoma supematants were screened for 
PRRSV specific antibodies with IFA on PRRSV-infected GRL11171 cells. Positive 
hybridomas were selected and cloned three times. MAbs were isotyped with 
commercial ELISA kit (Zymed Laboratories Inc.). 
Enzyme-linked immunosorbent assay (ELISA). Reactivity of the MAbs with PRRSV 
isolates was tested with fixed-cell ELISA as previously reported [23]. Briefly, cell 
monolayers inoculated with PRRSV isolates at 0.001 multiplicity of infection were 
incubated for 48 h and fixed with methanol. The free sites on the plates were 
blocked with 1 % BSA for one hour. Hybridoma culture fluids containing MAbs 
were diluted two-fold and added to the fixed-cell plates. Positive and negative 
MAbs were included as controls. Specific reactions were detected with goat anti-
mouse IgG (H+L) conjugated with peroxidase followed by addition of substrate 
2,2'-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS). Optical density at 
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405 nm (A405) was read with an ELISA reader. 
Antigenic variation analysis with the maximum parsimony. The software package 
of phylogenetic analysis using parsimony (PAUP) version 3.1.1 (Swofford D. L. 
1993) was used to analyze the antigenic variation among the PRRSV Isolates 
tested with MAbs to PRRSV GP2, GPS and M proteins. MAb titers were converted 
into ordered alphabetical character types for analysis with the software. The 
epitope trees were constructed with maximum parsimony methods and the 
consensus tree was generated based on semlstrict method by implementing the 
bootstrap analysis with 476 replicates. 
Result 
PRRSV specific MAbs to GP2, GP3 and M proteins. Hybridoma culture fluids were 
screened by IFA on cells Infected with PRRSV VR2385. Nine hybrldomas found 
positive by IFA were cloned as described in the methods section. Two of the MAbs 
were from mice Immunized with recombinant GP2 protein, three were from mice 
immunized with GP3 and four were from mice immunized with the M protein (Table 
1). All of them showed strong perinuclear fluorescence In VR2385 infected cells 
(Fig. 1), which was different from the cytoplasmic staining observed with PRRSV N 
protein-specific MAb [12]. No immunofluorescence was detected in the negative 
control cells. To determine the sensitivity of the epitopes to detergent treatment, we 
extracted PRRSV antigen with 1% Triton X-100 and tested its reactivity with the 
MAbs using ELISA. No clear reactivity was detected by ELISA between the MAbs 
and the PRRSV antigen, implying that the epitopes recognized by these MAbs 
were sensitive to detergent treatment and were possibly conformationally 
dependent. 
Reactivity with PRRSV field isolates and antigenic variation studies. Among these 
MAbs, only PP2bD6, PP3ec12, PP6dE3 and PP6dG12 reacted very weakly with 
Leiystad virus In IFA (data not shown) and hence no European PRRSV Isolates 
were included in the antigenic variation studies. Thirty-three PRRSV field Isolates 
from different U.S. states were propagated to test their reactivity with the MAbs in 
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fixed-cell ELISA. Different titers were obtained for the same MAb with different 
isolates and vice versa (Table 2), suggesting there is antigenic variation in GP2, 
GPS and M proteins among U.S. PRRSV isolates. ISU12HP (Table 2) was 
obtained through serial passage of VR2385 isolate in CRL11171 cells to passage 
85. In comparison with VR2385, the reactivity of ISU12HP was reduced with these 
MAbs, indicating variation after high passage in continuous cell line. 
Antigenic variation analysis with the maximum parsimony algorithm 
indicated that there were three virus groups among the 33 isolates (Fig. 1). In the 
epitope tree, isolates ISU1894, ISU28, ISU51, ISU4, RP12, RP16, RP18, RP17, 
RP40, RP11, RP49, RP20, RP29, RP30, RP31, RP45 and RP46 formed a branch. 
Isolates ISU30262, ISU3927, ISU412, RP23, RP10, ISU79, RP22, RP36 and RP50 
formed another branch. The remaining isolates did not form distinct branch. 
Isolates VR2385, ISU55 and ISU22 were closely related to each other in the tree 
diagram, which corresponds to the phylogenetic tree based on nucleotide 
sequence [16, 18]. 
Discussion 
We have successfully prepared MAbs to GP2, GP3 and M proteins of 
PRRSV. These MAbs reacted with PRRSV-infected cells specifically by 
immunofluorescence. The IFA results showed characteristic perinuclear staining 
with these MAbs against PRRSV. The perinuclear staining indicates that the 
proteins detected are possibly synthesized and accumulated in the endoplasmic 
reticulum and the Golgi complex in PRRSV-infected cells. In contrast, the PRRSV 
N protein is highly basic and hydrophilic, and is synthesized in the cytoplasm of 
PRRSV-infected cells [12]. 
All of the MAbs described in this study were possibly directed against 
conformationally dependent epitopes. No reactivity was found with ELISA between 
the MAbs and detergent extracted PRRSV antigen, suggesting that the 
corresponding epitopes of the MAbs were sensitive to detergent treatment. 
Western-blot analysis confirmed the observation in ELISA (data not shown). 
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We have described for the first time the preparation of MAbs to GP2 and GPS 
of North American PRRSV isolate and their use in antigenic variation studies. We 
have shown that among U.S. PRRSV field isolates there is antigenic variation 
detected by the MAbs to GP2, GPS and M proteins. This was detected by fixed-cell 
ELISA as most of these MAbs recognized conformationally dependent epitopes 
and these epitopes were preserved in fixed cells. The serial passage of VR2S85 in 
continuous cell line to passage 85 (ISU12HP) changed its reactivity with the MAbs, 
implying the epitope was modified during the serial passages. The difference in 
reactivity of MAbs with PRRSV isolates was consistent with the report about 
differences in the amino acid sequences of VR2385, ISU22, ISU55, ISU79, 
ISU1894, ISUS927 and RP45 isolates [16, 18]. Our results are also consistent with 
the previous reports on antigenic variation among PRRSV field isolates detected 
with monoclonal antibodies to GPS, GP4, M and N proteins [7, 22, 25]. 
All of the isolates used in this study were obtained before the widespread 
use of modified live PRRSV vaccines. Antigenic variation analysis with the 
maximum parsimony algorithm indicated that there are at least three groups among 
the SS isolates tested. In the epitope tree, all three isolates (RP17, RP18 and 
RP20) from Virginia State were in one group. Variation in deduced amino acid 
sequence as well as difference in virulence were observed amongst isolates 
VR2S85, ISU55, 1SU1894, ISU22, ISU79 and ISU3927 [9, 10, 16, 18]. Additional 
studies are needed to determine if there is any correlation between certain 
epitopes and pathogenicity. The MAbs described here should be helpful for further 
characterization of PRRSV structural proteins, antigenic variation and PRRSV 
pathogenesis. 
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Fig. 1. Reactivity of MAbs with PRRSV in infected ATCC CRL11171 cells. 
Perinuclear immunofluorescence was observed with MAb PP2eA1 (A), MAb 
PPSaCI (B) and MAb PP6aG6 (C) derived from mice immunized with the 
recombinant GP2, GPS and M proteins, respectively. No immunofluorescence was 
detected with negative control MAb PPAc8 (D). 
Fig. 2. Epitope tree based on reactivity of MAbs with PRRSV Isolates evaluated by 
PAUP 3.1.1 program. The name of PRRSV isolates, origin and year of isolation are 
given In Table 2. The numbers above branches indicate percentage of 29900 
trees in 476 replicates, which have the same arrangement. 
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Table 1. MAbs to PRRSV GP2, GPS and M proteins 
Identification Derived from 
immunization with 
Isotype 
PP2eA1 GP2 lgG2a 
PP2bD6 GP2 IgM 
PPSaCI GPS igG3 
PPSfBIG GPS IgGI 
PP3eC12 GPS IgM 
PP6aG6 M lgG3 
PP6cE5 M lgG2a 
PP6dE3 M IgM 
PP6dG12 M IgM 
Table 2. Reactivity^ of the MAbs with PRRSV field isolates detected with fixed-cell ELISA 
Virus Source Identification of MAbs to PRRSV 
isolates (year) 
2eA1 2bD6 3aC1 3fB10 3eC12 4bB3 6aG6 6cE5 6dE3 6dG12 
VR2385 Iowa (1991) 128 128 256 16 64 512 1024 32 128 512 
ISU12HP Iowa" 16 64 16 16 64 64 256 16 256 256 
ISU1894 Iowa 64 64 32 8 16 256 512 16 256 256 
1SU22 Iowa 64 128 256 16 64 256 1024 32 1024 1024 
ISU28 Iowa 16 128 128 8 256 512 512 16 128 128 
ISU30262 Iowa 256 128 256 64 64 256 1024 64 256 256 
ISU3927 Iowa 64 64 128 64 64 256 1024 16 256 128 
ISU4 Iowa <8 32 <8 <8 32 256 <8 <8 128 128 
ISU412 Iowa 64 128 512 64 64 256 1024 32 128 128 
ISU51 Iowa 16 256 16 <8 128 128 1024 8 256 128 
ISU55 Iowa 128 128 256 16 64 512 512 16 256 256 
ISU79 Iowa 128 32 256 32 64 256 1024 32 512 128 
RP10 Iowa (1994) 64 32 128 64 32 256 512 128 128 128 
RP11 Iowa (1994) 64 64 256 8 64 512 1024 8 512 128 
RP12 Iowa (1994) 8 32 8 <8 32 512 <8 <8 32 128 
RP15 Minnesota (1994) 64 32 32 16 16 256 512 32 32 64 
RP16 Minnesota (1994) 8 32 8 <8 64 8 <8 <8 32 32 
RP17 Virginia (1995) 8 32 <8 <8 32 128 <8 <8 128 64 
RP18 Virginia (1995) <8 32 <8 <8 64 512 <8 <8 512 16 
RP20 Virginia (1995) <8 128 8 8 64 128 8 8 512 128 
RP22 Iowa (1989) 128 256 256 32 128 1024 1024 32 512 512 
RP23 Iowa (1989) 128 128 512 64 64 256 1024 32 128 128 
RP24 Iowa (1989) 8 32 128 16 128 512 256 8 128 512 
a. Reactivity was expressed as titers of the reaction of MAbs with the PRRSV isolates. End-point titers were 
expressed as the reciprocal of the highest dilution of the MAbs showing absorbance A405 larger than the sunfi of 
average negative control's A405 plus 3 standard deviations. 
b. The isolates initiated with ISU were isolated from Iowa farms during 1991-1993. 
Table 2. (continued) 
Virus 
isolates 
Source 
(year) 
2eA1 2bD6 3aC1 
Identification of MAbs to PRRSV 
3fB10 3eC12 4bB3 6aG6 6cE5 6dE3 6dG12 
RP29 Iowa (1989) 32 32 16 8 16 512 512 16 32 64 
RP30 Iowa (1989) 64 32 32 8 32 256 512 16 128 128 
RP31 Iowa (1989) 16 32 16 8 32 256 512 16 128 128 
RP32 Iowa (1989) 128 32 256 16 32 256 512 32 256 64 
RP36 Iowa (1989) 64 32 128 32 32 64 1024 16 256 128 
RP38 Kentucky (1989) 32 64 64 16 64 256 1024 16 512 512 
RP40 Missouri(1991) 32 16 64 8 32 256 64 <8 64 32 
RP45 Minnesota (1993) 128 256 512 8 32 256 128 32 128 128 
RP46 Minnesota (1993) 16 64 8 8 32 64 1024 8 256 128 
RP49 Nebraska(1993) 64 64 256 8 64 512 1024 16 512 128 
RP50 Illinois (1993) 256 128 512 32 128 256 1024 32 256 64 
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GENERAL CONCLUSIONS 
Our experimental studies were designed to characterize the PRRSV proteins 
and analyze their function in host protection and in early virus infection. MAbs 
were developed for the research on viral proteins. Preparation of recombinant 
proteins and MAbs provides regents for further studies on subunit vaccines, 
structure-function relationship of viral proteins, and diagnostics. 
We have successfully expressed PRRSV ORFs 2 to 7 products using a 
baculovirus expression system, which was selected for its high yield of 
heterologous proteins and eukatyotic environment for post-transiational 
modifications. The expressed proteins reacted specifically with PRRSV antibodies 
in immunofluorescence assay and western-blot analysis, and induced antibodies 
to PRRSV in rabbits. Cell surface immunofluorescence studies suggested that the 
polypeptides encoded by ORFs 2 to 6 were membrane associated. This 
conclusion was based on our observation that the expressed proteins were 
detected on the cell surface of unfixed and unpermeabilized insect cells infected 
with the recombinant baculoviruses containing these genes. These results 
confirmed the predictions made from deduced amino acid sequence analysis 
(Meng et al., 1994, Morozov et al., 1995). The nature of membrane association of 
these proteins might be important in PRRS virus replication and virus assembly. In 
contrast, the nucleocapsid protein was a highly basic and hydrophilic protein and 
was expressed only in cytosol. 
The polypeptides encoded by ORFs 2 to 5 were found to be N-glycosylated. 
During the initiation of this study, there was little published infomnation available 
about these proteins. Expression of these proteins provided an alternative to study 
these proteins. Westem-blot analysis of recombinant proteins showed multiple 
bands for ORFs 3 to 5 products, which suggested differential glycosylation. 
Tunicamycin treatment of insect cells infected with recombinant baculoviruses 
containing ORFs 3 to 5 eliminated most of the bands. This drug was used to inhibit 
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N-linked glycosylation. For ORF 2 product, a 29 kDa band was eliminated after the 
drug treatment and a 25 kDa band appeared. Based on these studies, the core 
proteins for ORFs 2 to 5 were found to be 25, 27, 18, and 16 kDa, respectively. 
Other bands after the drug treatment might be due to other modifications, such as 
0-glycosylation and phosphorylation. 
These recombinant proteins Induced antibodies to PRRSV in rabbits, which 
indicated that these recombinant proteins had similar antigenicity to native 
counterparts. The reactivity of these antibodies with purified PRRSV In ELISA also 
suggested that the ORFs 2 to 7 products were virion associated proteins, which 
confirmed the reports about LV (VAN Nieuwstadt et a!., 1996 & Meulenberg et al., 
1996). 
To test the vaccine potential of these proteins in host protection, we 
immunized three-week old pigs with combinations of recombinant proteins. Partial 
protection against PRRS was observed in pigs Immunized with combination of 
GP2, GPS and GP4, and combination of GPS, M and N proteins. Average clinical 
respiratory disease scores of these two groups were reduced significantly (P < 
0.001) compared with that of control group, suggesting immunization reduced the 
clinical respiratory disease caused by PRRS. Compared with the average gross 
lung lesion score of control group, the average scores of these two test groups 
reduced significantly (P < 0.05) and Indicate that host immune response reduced 
the Incidence of pneumonia. However, the combination of GP5 and M proteins did 
not elicit any protection because Immunization with this combination resulted In a 
similar gross lung lesion score as that of control group though the clinical score 
was reduced. Virus Isolation was carried out to determine if immunization 
shortened duration of viremla In challenged pigs. Again, immunization with 
combination of GP2, GPS and GP4 proteins and combination of GP5, M and N 
proteins reduced the duration of viremla compared with that of the control group, 
but pigs immunized with a combination of GP5 and M had a similar length of 
viremla to that of control group. 
The immunization results Indicate that combination of GP2, GPS and GP4 
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proteins or combination of GPS, M and N proteins can Induce protection against 
PRRS. It seems that Inclusion of N protein might be Important In Inducing host 
protection, which Is different from the report that N protein did not have any effect in 
sow immunization (Duran et a!., 1997). The difference could be due to different 
strains used as European and U.S. PRRSV belong to different genotype (MardassI 
et aL, 1994; Meng et a!., 1994; Meng et al., 1995a; Meng et al., 1995b). The N 
protein could induce cell-mediated immunity In immunized pigs. Future studies are 
warranted to elucidate the exact mechanism of this protection and to test the ability 
of the protection against heterologous challenge. The development of subunit 
vaccines will benefit PRRS control and eradication programs because subunit 
vaccines do not cause virus shedding as modified live virus vaccine and Its use 
can be differentiated from PRRSV Infection. 
Further studies on viral proteins needed monoclonal antibodies in functional 
analysis. MAbs against PRRSV GP2, GP3, GP4, GPS and M proteins were not 
available at the beginning of this project. These proteins are membrane 
associated proteins, which by their location on the virion surface are important in 
virus binding/entry and PRRSV pathogenesis. We prepared monoclonal 
antibodies to them. Four MAbs were developed to GP4 and six MAbs to GPS 
protein. Two MAbs to GP2, three MAbs to GPS and four MAbs to M protein were 
prepared. They were specific as they reacted with PRRSV antigen In 
Immunofluorescence assay and fixed-cell ELISA. Typical perinuclear staining was 
observed with these MAbs, suggesting that these proteins were synthesized and 
accumulated in the endoplasmic reticulum and Golgi complex In PRRSV-lnfected 
cells. This result also indicated they were membrane associated proteins. In 
contrast, the N protein is highly basic and synthesized In cytosol as staining with 
MAb to N yielded cytoplasmic fluorescence. 
Most of the MAbs generated were against conformationally dependent 
epitopes. They failed to react with detergent extracted PRRSV antigen In ELISA 
and western-blot analysis. Only two out of ten MAbs to GP4 and GPS showed 
reaction with PRRSV antigen In ELISA and one MAb to GPS reacted with PRRSV 
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antigen in westem-blot. The con-esponding epitopes of other MAbs were sensitive 
to detergent treatment and conformationally dependent. One MAb to GPS reacted 
with a 26 kDa protein in westem-blot, which confirmed that it reacted with a linear 
epitope on GPS protein. The GPS protein has surface epitopes as one MAb 
showed neutralizing activity, which is consistent with a recent report (Pirzadeh & 
Dea, 1997). 
Antigenic variation among PRRSV field isolates was found with these MAbs. 
Different reactivity of field isolates with these MAbs was observed in fixed-cell 
ELISA. Among the 23 PRRSV isolates tested, there were four groups based on 
reactivities with MAbs to GP4 and GPS proteins. Among the 33 PRRSV isolated 
tested with MAbs to GP2, GP3 and M proteins, there were at least three groups 
based on an epitope tree constructed with the maximum parsimony algorithm. 
These isolates were obtained before the widespread use of modified live PRRSV 
vaccines and should represent antigenic variation in PRRSV isolates in that period. 
The serial passage of VR238S in a continuous cell line to high passage changed 
its reactivity with the MAbs, implying the epitope modification, which may be the 
basis of preparation of modified live virus vaccine through this approach. The 
difference in reactivity of MAbs with PRRSV field isolates revealed antigenic 
variation, which was consistent with report on the variability observed in deduced 
amino acid sequences of PRRSV VR238S, iSU1894, 1SU3927, ISU22, ISUSS and 
RP45 isolates (Meng et al., 199Sa). The antigenic variation observed in our study 
was consistent with published reports of studies with MAbs to other viral proteins of 
PRRSV (Nelson et al., 1993; Drew et al., 199S; Wieczorek-Krohmer et al., 1996). 
These results confirmed the existence of two different genotypes of PRRSV and 
antigenic variation among different PRRSV field isolates in each genotype. The 
antigenic variation might help PRRSV escape the host immune response, which 
results in persistent infection. It might also influence virus binding/entry to target 
cells, and hence the virulence of virus might be reduced. The antigenic variation 
makes it neariy impossible to develop a vaccine efficacious for all PRRSV Isolates. 
The occurrence of acute PRRS in vaccinated herds in 1996 demonstrates the 
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problem. However, It Is not yet known how antigenic variation affects virus-cell 
interaction, virus replication and pathogenesis of PRRSV. Future studies should be 
pursued to elucidate the mechanism and effects of antigenic variation of PRRSV, 
which will provide valuable information for PRRSV control and eradication. 
The third manuscript describes the preliminary characterization of PRRSV 
receptor on CRL11171 cells and the detection of an 18 kDa protein binding to the 
cells. The PRRSV receptor and the viral protein(s) that serves as virus attachment 
protein(s) have not been defined. Studies on PRRSV receptor and virus-cell 
interaction are important for studies on PRRSV cell tropism and pathogenesis as 
well as for anti-viral drug design. PRRSV bound to CRL11171 cells in a saturable 
way, which suggests the specific interaction with receptor. The binding was 
blocked with purified PRRSV particles. Limited PRRSV receptor on the cell surface 
was suggested to account for the low percentage of binding of radiolabeled 
PRRSV particles. The limited receptor density suggests that the receptor 
molecules are dynamic and only a certain population of cells express the 
molecules at certain time point. The binding percentage was similar to that of LDV, 
which binds to a subset of mouse macrophages (Kowalchyk & Plagemann, 1985). 
PRRSV receptor contained protein moieties as protease treatment of cell 
monolayers reduced virus binding significantly. Lipid was possibly involved in 
receptor integrity as phospholipase C reduced PRRSV binding at high 
concentration. The enzyme treatment of target cells to test the effect of such 
treatment on virus binding is a commonly used method to determine whether a viral 
receptor is a protein, lipid or carbohydrate moiety (Armstrong etal., 1984, Komai et 
al., 1988, Schlegel etal., 1983). PRRSV receptor activity was extracted with 
detergent OG as vims binding was reduced after OG treatment. The nonionic OG 
extraction has been used to extract the receptors for vesicular stomatitis virus, 
polyoma virus, Semliki Forest virus and Simian virus 40 from intact cell monolayers 
(Clayson & Gompans, 1989, Helenius etal., 1978, Marriott et al., 1987, Schlegel et 
al., 1983). OG has been used for the noncytolytic extraction of surface proteins and 
extracted solutions have been examined for the presence of virus binding proteins 
1 1 1  
(Clayson & Compans, 1989, Marriott etal., 1987). in our study, no specific band 
was found after immunoprecipitation of OG extract with purified PRRSV virions, 
implying the low density of PRRSV receptor on the cell surface. This result was 
consistent with the binding assay which showed low percentage of binding. 
To identify which viral protein Is involved in virus binding, we perfomned a 
virus binding blocking assay. Recombinant proteins of GP2, GPS , GP4, GPS, M 
and N were tested and none of them showed blocking effect. The result indicated 
that the Interaction between different viral proteins could be important in 
maintaining proper conformation of receptor binding epitopes in PRRSV virion. 
An 18 kDa protein of PRRSV bound to GRL11171 cells and was probably 
the M protein. The 18 kDa protein binding to target cells remained after three 
washes with PBS demonstrating its specific binding. This binding was absent from 
radiolabeled normal cell lysate added to the cells. Inhibition of glycosylation with 
tunicamycin in PRRSV-infected cells did not affect the 18 kDa protein binding, 
indicating that glycosylation was not necessary for the binding activity. However, 
our experiment did not exclude the possibility that glycosylation may be important 
in the infectious virion to maintain correct conformation of viral surface structures. 
The disulfide-linked GP5-M protein heterodimer in virions (Mardassi etal., 1996) 
may play important roles in this context. 
The 18 kDa protein in lysate of cells with attached proteins was 
immunoprecipitated by monoclonal antibodies against M protein, indicating it was 
the M protein. It is surprising because the M is a transmembrane protein without 
any glycosylation (Meulenberg et al., 1995). It has been speculated that GPS is the 
viral attachment protein. Monoclonal antibodies against GP4 and GPS have been 
associated with neutralizing activity (Pirzadeh & Dea, 1997, Van Nieuwstadt etal., 
1996), suggesting their involvement in virus-cell Interaction. However, it has not 
been demonstrated which PRRSV protein is the viral attachment protein. These 
glycoproteins could be involved In initial contact of virus to target cells and the 
neutralizing monoclonal antibody binding abolishes virus-cell interaction. The M 
protein might be responsible for secondary binding or membrane fusion, which 
1 1 2  
might be the reason that disruption of the disulfide bond of ORFs 5 and 6 products 
abolishes LDV infectivity (Faaberg etai, 1995). 
Although we have demonstrated that M protein adheres to target cells in our 
assay, our studies do not unequivocally establish M as the PRRSV viral attachment 
protein. The binding assay employing metabolically labeled viral proteins may not 
accurately reflect events that mediated virus binding of infectious virions to cells. 
They do, however, provide clues to the virus-cell interaction. Further studies on 
PRRSV receptor and viral attachment protein(s) will provide more evidence on 
virus-cell interactions and offer clues for PRRSV pathogenesis and a target for 
antiviral drug design. 
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